Processing 00000000.tx.1: Genetics of the APM1 Locus and Its Contribution to Type 2 Diabetes Susceptibility in French Caucasians Fernando Gibson1, and Philippe Froguel1,2 1 Genomic Medicine, Imperial College, London, U.K 2 CNRS 8090, Institut de Biologie de Lille, Institut Pasteur, Lille, France  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  We have carried out a detailed reexamination of the genetics of the APM1 locus and its contribution to the genetic basis of type 2 diabetes susceptibility in the French Caucasian population. 

Phrase: "Genetics of the APM1 Locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]

Phrase: "and"

Phrase: "Its Contribution to Type 2 Diabetes Susceptibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "in French Caucasians Fernando Gibson1,"

Phrase: "and"

Phrase: "Philippe Froguel1,"

Phrase: "2 1 Genomic Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013227:Medicine, NOS [Pharmacologic Substance]
   812   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "Imperial College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557806:College [Manufactured Object]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "U.K 2 CNRS 8090,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1708601:K' [Quantitative Concept]

Phrase: "Institut de Biologie de Lille,"

Phrase: "Institut Pasteur,"

Phrase: "Lille,"

Phrase: "France  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "a detailed reexamination of the genetics of the APM1 locus"

Phrase: "and"

Phrase: "its contribution to the genetic basis of type 2 diabetes susceptibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1880177:Contribution [Activity]

Phrase: "in the French Caucasian population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.2: The G allele of single nucleotide polymorphism 11426 in the APM1 promoter showed modest association with type 2 diabetes (odds ratio 1.44 [95% CI 1.041.98]; P = 0.03), providing corroborative evidence that single nucleotide polymorphisms in the APM1 promoter region contribute to the genetic risk of type 2 diabetes. 

Phrase: "The G allele of single nucleotide polymorphism 11426"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002085:Allele [Gene or Genome]

Phrase: "in the APM1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "modest association with type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C3645563:Association type [Intellectual Product]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "(odds ratio 1.44"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "[95% CI 1.041.98"

Phrase: "]"

Phrase: "; P = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "corroborative evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that single nucleotide polymorphisms in the APM1 promoter region"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   742   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0032529:polymorphisms [Genetic Function]
   742   C0037179:Single [Population Group]
   742   C0087136:single [Finding]
   742   C0205171:Single [Quantitative Concept]
   708 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "contribute to the genetic risk of type 2 diabetes."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0011860:Type 2 Diabetes [Disease or Syndrome]
   764   C0441730:Type 2 [Classification]
   764   C1517512:Genetic Risk [Quantitative Concept]
   762   C1171304:diabetes risk [Quantitative Concept]
   762   C1320657:Diabetes type [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   742   C0035647:Risk [Qualitative Concept]
   742   C0314603:Genetic [Functional Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1880177:Contribute [Activity]
   734   C0260581:birth type [Health Care Activity]
Processing 00000000.tx.3: A "sliding window" analysis identified haplotypes 1-1-1, 1-1-1-1, and 1-1-1-1-1 as being strongly protective against type 2 diabetes (P 0.0001). 

Phrase: "A ""sliding window"" analysis identified haplotypes 1-1-1,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   791   C0002778:Analysis [Laboratory Procedure]
   791   C0018591:Haplotypes [Organism Attribute]
   791   C0205396:Identified [Qualitative Concept]
   791   C0332246:Sliding [Functional Concept]
   791   C0557702:Window [Manufactured Object]
   791   C0936012:Analysis [Research Activity]
   791   C1272706:Window [Temporal Concept]
   791   C1524024:analysis [Functional Concept]
   791   C1550043:Identified [Finding]
   791   C1551388:Identified [Functional Concept]
   791   C1704674:Window [Manufactured Object]
   758 E C0444330:Slide [Research Device]
   758 E C1705201:Slide [Manufactured Object]

Phrase: "1-1-1-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "1-1-1-1-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2827734:1+ [Quantitative Concept]
   804   C2981698:1+ [Classification]

Phrase: "as"

Phrase: "being"

Phrase: "strongly protective against type 2 diabetes"

Phrase: "(P 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.4: Evidence is presented that the APM1 gene is a locus of low linkage disequilibrium, high haplotype diversity, and high recombination. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "that"

Phrase: "the APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "a locus of low linkage disequilibrium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708726:Locus [Gene or Genome]

Phrase: "high haplotype diversity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1880371:Diversity [Qualitative Concept]

Phrase: "and"

Phrase: "high recombination."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034865:Recombination [Genetic Function]
Processing 00000000.tx.5: We were unable to obtain data to support the hypothesis that genetic variation in the APM1 gene is a major contributor to the type 2 diabetes linkage result at chromosome 3q27. 

Phrase: "We"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "data to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that genetic variation in the APM1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0042333:Genetic Variation [Natural Phenomenon or Process]
   748   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "a major contributor to the type 2 diabetes linkage result"

Phrase: "at chromosome 3q27."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521326:3q27 [Cell Component]
Processing 00000000.tx.6: Finally, in families with early-onset type 2 diabetes, we obtained suggestive evidence of a linkage peak for serum adiponectin levels (logarithm of odds = 2.1) that closely matched the position of the type 2 diabetes linkage peak. 

Phrase: "Finally,"

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with early-onset type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0011860:Type 2 Diabetes [Disease or Syndrome]
   853   C1320657:type diabetes [Finding]
   840   C0441730:Type 2 [Classification]
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C0332307:Type [Qualitative Concept]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "we"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "suggestive evidence of a linkage peak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "for serum adiponectin levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(logarithm of odds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986775:Logarithm [Occupational Activity]

Phrase: "= 2.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "that closely"

Phrase: "matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:matched [Research Activity]
  1000   C1708943:Matched [Qualitative Concept]

Phrase: "the position of the type 2 diabetes linkage peak."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0733755:Position [Spatial Concept]
Processing 00000000.tx.7: This result indicated that the type 2 diabetes susceptibility locus at 3q27 influences both genetic predisposition to type 2 diabetes and serum adiponectin levels in patients with type 2 diabetes. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the type 2 diabetes susceptibility locus at 3q27 influences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1708726:Locus [Gene or Genome]

Phrase: "both genetic predisposition to type 2 diabetes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0314657:Genetic Predisposition [Organism Attribute]
   748   C0012655:Predisposition [Clinical Attribute]
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0220898:Predisposition [Organism Attribute]
   748   C0314603:Genetic [Functional Concept]
   746   C0260581:birth type [Health Care Activity]

Phrase: "and"

Phrase: "serum adiponectin levels in patients"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0229671:Serum [Body Substance]
   760   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.8: The strong correlation between the twin global epidemics of obesity and type 2 diabetes and the identification of obesity as a major cause of type 2 diabetes is now well established (14). 

Phrase: "The strong correlation between the twin global epidemics of obesity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "the identification of obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "as a major cause"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015127:cause [Functional Concept]
   861   C0205164:Major [Qualitative Concept]
   861   C1524003:Cause [Conceptual Entity]

Phrase: "of type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "now well established"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205170:Well [Qualitative Concept]
   827   C0443211:Established [Qualitative Concept]
   827   C1272684:Established [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.9: It has also become clear that adipose tissue rather than being a passive energy storehouse is, in fact, an active endocrine organ secreting a variety of proteins that regulate glucose levels, lipid metabolism, and energy homeostasis (57), including leptin (8,9), tumor necrosis factor- (10,11), and resistin (12,13). 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "become"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "rather than"

Phrase: "being"

Phrase: "a passive energy storehouse"

Phrase: "is"

Phrase: ","

Phrase: "in fact,"

Phrase: "an active endocrine organ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1305733:Endocrine organ [Body Part, Organ, or Organ Component]
   827   C0178784:Organ [Body Part, Organ, or Organ Component]

Phrase: "secreting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreting [Cell Function]

Phrase: "a variety of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "that"

Phrase: "regulate"

Phrase: "glucose levels,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0428548:glucose levels [Laboratory or Test Result]
   966 E C0337438:glucose level [Laboratory Procedure]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "lipid metabolism,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "energy homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3157043:energy homeostasis [Biologic Function]
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "(57"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "leptin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1416825:LEPTIN [Gene or Genome]

Phrase: "(8,"

Phrase: "9"

Phrase: ")"

Phrase: ","

Phrase: "tumor necrosis factor-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "(10,"

Phrase: "11"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "resistin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1426906:RESISTIN [Gene or Genome]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.10: Another adipose-secreted protein that has attracted a lot of attention recently is adiponectin, an abundant plasma protein encoded by the APM1 gene. 

Phrase: "Another adipose-secreted protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "has"

Phrase: "attracted"

Phrase: "a lot of attention recently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1115660:LOT [Intellectual Product]
   760   C1518000:Lot [Qualitative Concept]
   760   C1710198:Lot [Idea or Concept]

Phrase: "is"

Phrase: "adiponectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "an abundant plasma protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "encoded by the APM1 gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017337:Gene [Gene or Genome]
   760   C0679058:encoded [Mental Process]
   760   C1540187:APM1 [Gene or Genome]
   760   C2700640:Encoded [Activity]
   760   C2986675:APM1 [Gene or Genome]
Processing 00000000.tx.11: In pharmacological studies, the administration of adiponectin caused weight loss and lowered plasma glucose in mice that were fed a high-fat and -sucrose diet (14). 

Phrase: "In pharmacological studies,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1831759:pharmacological studies [Diagnostic Procedure]
   861   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   861   C0205464:pharmacological [Functional Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   789 E C1524059:pharmacology [Functional Concept]

Phrase: "the administration of adiponectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001554:Administration [Occupational Activity]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "weight loss"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0043096:WEIGHTLOSS [Finding]
  1000   C2911645:Weight loss [Finding]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1517945:Loss [Quantitative Concept]
   861   C1705104:Weight [Idea or Concept]

Phrase: "and"

Phrase: "lowered plasma glucose in mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0202042:Plasma glucose [Laboratory Procedure]
   806   C0455280:plasma glucose [Laboratory or Test Result]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0032105:Plasma [Body Substance]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "that"

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "a high-fat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205250:High [Qualitative Concept]
   861   C0424612:FAT [Organism Attribute]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "and -"

Phrase: "sucrose diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.12: Adiponectin was also shown to stimulate glucose uptake and fatty acid oxidation via the phosphorylation and activation of 5'-AMPactivated protein kinase (15). 

Phrase: "Adiponectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "fatty acid oxidation via the phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1158366:fatty acid oxidation [Molecular Function]
   790   C0015684:Fatty acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0030011:Oxidation [Molecular Function]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "activation of 5'-AMPactivated protein kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C1819041:protein kinase activation [Cell Function]
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.13: The data from adiponectin knockout studies have been conflicting, with adiponectin-deficient mice exhibiting moderate insulin resistance with glucose intolerance (16); 

Phrase: "The data from adiponectin knockout studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681873:study data [Research Activity]
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "have"

Phrase: "been"

Phrase: "conflicting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009671:conflicting [Individual Behavior]
   966 E C1705242:Conflict [Qualitative Concept]

Phrase: ","

Phrase: "with adiponectin-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "moderate insulin resistance with glucose intolerance"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(16"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.14: insulin resistance, but only when fed a high-fat and -sucrose diet (17); 

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "when"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "a high-fat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205250:High [Qualitative Concept]
   861   C0424612:FAT [Organism Attribute]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "and -"

Phrase: "sucrose diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: "(17"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.15: and normal plasma glucose and insulin levels (18). 

Phrase: "and"

Phrase: "normal plasma glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0860800:normal glucose [Finding]
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   734   C0440742:Normal plasma [Body Substance]

Phrase: "and"

Phrase: "insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0202098:insulin levels [Laboratory Procedure]
  1000   C0428405:insulin levels [Laboratory or Test Result]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.16: An interesting prospective study in rhesus monkeys showed that adiponectin levels decreased in parallel with the development of insulin resistance and type 2 diabetes (1921). 

Phrase: "An interesting prospective study in rhesus monkeys"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0033522:prospective study [Research Activity]
   778   C1709709:Prospective Study [Research Activity]
   748   C0023981:prospective [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that adiponectin levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "in parallel with the development of insulin resistance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0150312:In [Quantitative Concept]
   744   C0332285:In [Spatial Concept]
   744   C2348042:Parallel [Qualitative Concept]
   744   C2826345:PARALLEL [Research Activity]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(1921"

Phrase: ")."
Processing 00000000.tx.17: In humans, adiponectin levels are significantly reduced in individuals with obesity (22) and type 2 diabetes (19) relative to control subjects and are correlated with the level of insulin sensitivity and insulinemia (21). 

Phrase: "In humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "adiponectin levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "significantly"

Phrase: "reduced in individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0392756:Reduced [Qualitative Concept]
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "with obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(19"

Phrase: ")"

Phrase: "relative to control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "are"

Phrase: "correlated with the level of insulin sensitivity"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   778   C0920563:Insulin Sensitivity [Pathologic Function]
   774   C0202098:Insulin level [Laboratory Procedure]
   774   C0428405:insulin level [Laboratory or Test Result]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1547707:Level [Geographic Area]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1707520:Correlated [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulinemia"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.18: These observations suggested that low plasma adiponectin may contribute to the pathogenesis of insulin resistance and type 2 diabetes and, therefore, that the APM1 gene is a candidate type 2 diabetes susceptibility gene. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that low plasma adiponectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "contribute to the pathogenesis of insulin resistance"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0237834:Resistance [Mental Process]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1880177:Contribute [Activity]
   738   C0332325:Resistant to [Functional Concept]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "therefore,"

Phrase: "that"

Phrase: "the APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "a candidate type 2 diabetes susceptibility gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   895   C1332838:Candidate Gene [Gene or Genome]
   827   C0919453:Susceptibility Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.19: The APM1 gene maps to chromosome 3q27, a region identified as a susceptibility locus for the metabolic syndrome (23) and type 2 diabetes (24). 

Phrase: "The APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "maps to chromosome 3q27,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0814036:chromosome map [Intellectual Product]
   770   C0008633:Chromosome [Cell Component]
   770   C0024779:Map [Manufactured Object]
   770   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1521326:3q27 [Cell Component]
   770   C1706473:Map [Conceptual Entity]

Phrase: "a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "identified as a susceptibility locus"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0205396:Identified [Qualitative Concept]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1708726:Locus [Gene or Genome]

Phrase: "for the metabolic syndrome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0524620:Metabolic syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.20: Scanning the gene for single nucleotide polymorphisms (SNPs) in the Japanese (25) and French Caucasian (26) populations revealed 10 common (frequency >5%) SNPs. 

Phrase: "Scanning"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0034606:Scanning [Diagnostic Procedure]
  1000   C0441633:Scanning [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "the gene for single nucleotide polymorphisms (SNPs)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0678951:gene polymorphisms [Genetic Function]
   753   C0017337:Gene [Gene or Genome]

Phrase: "in the Japanese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556094:Japanese [Population Group]

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "French Caucasian"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007457:Caucasian [Population Group]
   861   C0043157:Caucasian [Population Group]

Phrase: "(26"

Phrase: ")"

Phrase: "populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "10 common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205214:Common [Quantitative Concept]
   861   C1522138:Common [Functional Concept]
   861   C3245511:common [Intellectual Product]

Phrase: "(frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: ">5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "SNPs."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.21: SNPs +45 and +276, in exon 2 and intron 2, respectively, were found to be associated with type 2 diabetes in the Japanese (25), whereas in French Caucasians, a haplotype including SNPs 11391 and 11377 in the proximal promoter region of the APM1 gene was associated with both adiponectin levels and type 2 diabetes (26). 

Phrase: "SNPs +45"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and +"

Phrase: "276,"

Phrase: "in exon 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "intron 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "respectively,"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the Japanese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556094:Japanese [Population Group]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "whereas in French Caucasians,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007457:Caucasians [Population Group]
   770   C0043157:Caucasians [Population Group]
   770   C1556084:French [Population Group]

Phrase: "a haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "SNPs 11391"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "11377 in the proximal promoter region of the APM1 gene"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   757   C0314621:Promoter gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0017446:Region [Geographic Area]
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205107:Proximal [Spatial Concept]
   739   C0205147:Region [Spatial Concept]
   739   C1540187:APM1 [Gene or Genome]
   739   C2986675:APM1 [Gene or Genome]

Phrase: "was"

Phrase: "associated with both adiponectin levels"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1547707:Level [Geographic Area]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.22: In a recent study in the Swedish Caucasian population (27), SNPs 11426 and 11377 were associated with type 2 diabetes, providing additional evidence that SNPs in the promoter region of the APM1 gene contribute to the genetic risk of type 2 diabetes. 

Phrase: "In a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "in the Swedish Caucasian population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "SNPs 11426"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "11377"

Phrase: "were"

Phrase: "associated with type 2 diabetes,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "additional evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that SNPs in the promoter region of the APM1 gene"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   751   C0678951:gene polymorphisms [Genetic Function]
   736   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0032529:polymorphisms [Genetic Function]
   736   C0037179:Single [Population Group]
   736   C0087136:single [Finding]
   736   C0205171:Single [Quantitative Concept]
   703 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "contribute to the genetic risk of type 2 diabetes."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0011860:Type 2 Diabetes [Disease or Syndrome]
   764   C0441730:Type 2 [Classification]
   764   C1517512:Genetic Risk [Quantitative Concept]
   762   C1171304:diabetes risk [Quantitative Concept]
   762   C1320657:Diabetes type [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   742   C0035647:Risk [Qualitative Concept]
   742   C0314603:Genetic [Functional Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1880177:Contribute [Activity]
   734   C0260581:birth type [Health Care Activity]
Processing 00000000.tx.23: In this report, we present a detailed reexamination of the genetics of the APM1 locus and its contribution to the genetic basis of susceptibility of type 2 diabetes in the French Caucasian population. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "a detailed reexamination of the genetics of the APM1 locus"

Phrase: "and"

Phrase: "its contribution to the genetic basis of susceptibility of type 2 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1880177:Contribution [Activity]

Phrase: "in the French Caucasian population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.24: Genetic variants in the APM1 gene were tested for association with type 2 diabetes in a new case-control study. 

Phrase: "Genetic variants in the APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variants [Qualitative Concept]

Phrase: "were"

Phrase: "tested for association"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0392366:tested [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in a new case-control study."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   923   C0007328:Case-Control Study [Research Activity]
   875   C0085973:Case Study [Intellectual Product]
   861   C0872128:case control [Health Care Activity]
   812   C0243148:control [Qualitative Concept]
   812   C0557651:Study [Manufactured Object]
   812   C0868928:Case [Functional Concept]
   812   C1550141:Control [Substance]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C2603343:Study [Research Activity]
   812   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.25: We characterized the relationship between the pattern of linkage disequilibrium (LD) across the APM1 gene, the APM1 haplotype diversity, and the APM1 locus-specific recombination rate. 

Phrase: "We"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the relationship between the pattern of linkage disequilibrium (LD)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]

Phrase: "across the APM1 gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "the APM1 haplotype diversity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1880371:Diversity [Qualitative Concept]

Phrase: "and"

Phrase: "the APM1 locus-specific recombination rate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0871208:Rate [Activity]
   804   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.26: In addition, we assessed the contribution of APM1 SNPs to the evidence for linkage of type 2 diabetes to chromosome 3q27 (24). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the contribution of APM1 SNPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "to the evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "of type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "to chromosome 3q27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521326:3q27 [Cell Component]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.27: Finally, evidence is presented that the type 2 diabetes susceptibility locus at 3q27 influences serum adiponectin levels in individuals with type 2 diabetes.  

Phrase: "Finally,"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "that"

Phrase: "the type 2 diabetes susceptibility locus at 3q27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1708726:Locus [Gene or Genome]

Phrase: "influences"

Phrase: "serum adiponectin levels in individuals"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0229671:Serum [Body Substance]
   760   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.28: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The American Diabetes Association 2003 criteria (28) for the classification of diabetes or normoglycemia were applied. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The American Diabetes Association 2003 criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0243161:criteria [Intellectual Product]
   717   C1705019:American Diabetes Association [Professional Society]

Phrase: "(28"

Phrase: ")"

Phrase: "for the classification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008902:Classification [Classification]
  1000   C0008903:classification [Functional Concept]
  1000   C0678229:classification [Occupational Activity]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "or"

Phrase: "normoglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0580545:Normoglycaemic [Finding]

Phrase: "were"

Phrase: "applied."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.29: The subset of 55 families with early-onset type 2 diabetes (age at diagnosis <46 years) who produced the linkage result at chromosome 3q27 was described previously (24). 

Phrase: "The subset of 55 families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515021:Subset [Classification]

Phrase: "with early-onset type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0011860:Type 2 Diabetes [Disease or Syndrome]
   853   C1320657:type diabetes [Finding]
   840   C0441730:Type 2 [Classification]
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C0332307:Type [Qualitative Concept]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "(age at diagnosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1828181:Age at diagnosis [Clinical Attribute]
   790   C0001779:Age [Organism Attribute]

Phrase: "<46 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "who"

Phrase: "produced"

Phrase: "the linkage result at chromosome 3q27"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "was"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.30: These families had the following affected sibling pair (ASP) composition: 41 families had one ASP, 11 had three ASPs, and 3 had six ASPs, giving a total of 92 ASPs. 

Phrase: "These families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "had"

Phrase: "the following affected sibling pair (ASP) composition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0486616:Composition [Clinical Attribute]
   804   C1555710:composition [Idea or Concept]

Phrase: ":"

Phrase: "41 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "had"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "ASP,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0037047:Sibling [Family Group]
   827   C0392760:Affected [Functional Concept]
   827   C1314939:Affected [Functional Concept]
   827   C1611273:Sibling [Intellectual Product]
   827   C1709450:Pair [Qualitative Concept]
   793 E C0001721:Affect [Mental Process]

Phrase: "11"

Phrase: "had"

Phrase: "three ASPs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206293:Asp [Reptile]
   861   C3541260:ASP [Gene or Genome]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "had"

Phrase: "six ASPs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206293:Asp [Reptile]
   861   C3541260:ASP [Gene or Genome]

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a total of 92 ASPs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
Processing 00000000.tx.31: Our case-control study was carried out with a cohort of 812 unrelated type 2 diabetic subjects (age 57  11 years; 

Phrase: "Our case-control study"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0007328:Case-Control Study [Research Activity]
   913   C0085973:Case Study [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0868928:Case [Functional Concept]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2603343:Study [Research Activity]
   827   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with a cohort of 812 unrelated type 2 diabetic subjects"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   756   C0441730:Type 2 [Classification]
   738   C0241863:DIABETIC [Finding]
   738   C0332307:Type [Qualitative Concept]
   738   C0439787:Out [Spatial Concept]
   738   C0445356:Unrelated [Finding]
   738   C0599755:Cohort [Population Group]
   738   C0849355:Out [Qualitative Concept]
   738   C1547052:*Type [Quantitative Concept]
   738   C1704623:Unrelated [Qualitative Concept]
   704   C0681850:Subject [Group]
   704   C1550501:{Subject} [Idea or Concept]
   704   C1706203:Subject [Idea or Concept]
   704   C2349001:Subject [Human]
   704   C2697811:Subject [Functional Concept]

Phrase: "(age 57  11 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   902   C1510829:Age-Years [Temporal Concept]
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.32: BMI 34.2  10.3 kg/m2; 

Phrase: "BMI 34.2  10.3 kg/m2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0456689:kg/m2 [Quantitative Concept]
   795   C0457242:m2 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.33: male/female 48:52%) and 1,044 unrelated normoglycemic subjects (age 49  14 years; 

Phrase: "male/female 48"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0015780:Female [Finding]
   827   C0024554:Male [Finding]
   827   C0043210:female [Population Group]
   827   C0086287:female [Population Group]
   827   C0086582:male [Population Group]
   827   C1705497:Female [Qualitative Concept]
   827   C1705498:Female [Qualitative Concept]
   827   C1706180:Male [Qualitative Concept]
   827   C1706428:Male [Qualitative Concept]
   827   C1706429:Male [Organism Attribute]

Phrase: ":"

Phrase: "52%"

Phrase: ")"

Phrase: "and"

Phrase: "1,044 unrelated normoglycemic subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C0681850:Subject [Group]
   771   C1550501:{Subject} [Idea or Concept]
   771   C1706203:Subject [Idea or Concept]
   771   C2349001:Subject [Human]
   771   C2697811:Subject [Functional Concept]

Phrase: "(age 49  14 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   902   C1510829:Age-Years [Temporal Concept]
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.34: BMI 30.7  10.4 kg/m2; 

Phrase: "BMI 30.7  10.4 kg/m2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0456689:kg/m2 [Quantitative Concept]
   795   C0457242:m2 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.35: male/female 34:66%). 

Phrase: "male/female 34"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0015780:Female [Finding]
   827   C0024554:Male [Finding]
   827   C0043210:female [Population Group]
   827   C0086287:female [Population Group]
   827   C0086582:male [Population Group]
   827   C1705497:Female [Qualitative Concept]
   827   C1705498:Female [Qualitative Concept]
   827   C1706180:Male [Qualitative Concept]
   827   C1706428:Male [Qualitative Concept]
   827   C1706429:Male [Organism Attribute]

Phrase: ":"

Phrase: "66%"

Phrase: ")."
Processing 00000000.tx.36: The type 2 diabetic patients were composed of 307 probands from type 2 diabetic families, 274 probands from obese families (29), and 231 singleton type 2 diabetic subjects who were recruited from the Corbeil region of France. 

Phrase: "The type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "composed of 307 probands"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0702111:probands [Organism Attribute]
   737 E C1948021:Proband [Family Group]

Phrase: "from type 2 diabetic families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]

Phrase: "274 probands from obese families"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0702111:probands [Organism Attribute]
   726 E C1948021:Proband [Family Group]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "231 singleton type 2 diabetic subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   766   C0681850:Subject [Group]
   766   C1550501:{Subject} [Idea or Concept]
   766   C1706203:Subject [Idea or Concept]
   766   C2349001:Subject [Human]
   766   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "were"

Phrase: "recruited from the Corbeil region of France."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0016674:France [Geographic Area]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
Processing 00000000.tx.37: The normoglycemic control subjects were composed of 264 husbands or wives from type 2 diabetic families, 268 subjects from a general population recruited in the Fleurbaix region of France, and 512 obese family probands. 

Phrase: "The normoglycemic control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "composed of 264 husbands"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0242664:Husbands [Family Group]
   737 E C1619821:husband [Intellectual Product]

Phrase: "or"

Phrase: "wives from type 2 diabetic families,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0242665:Wives [Family Group]
   719 E C1556153:wife [Intellectual Product]

Phrase: "268 subjects from a general population"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "recruited in the Fleurbaix region of France,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0016674:France [Geographic Area]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "512 obese family probands."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0702111:probands [Organism Attribute]
   779 E C1948021:Proband [Family Group]
   741 E C0702110:Propositus [Organism Attribute]
Processing 00000000.tx.38: Case patients and control subjects were of Northern French Caucasian ancestry. 

Phrase: "Case patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were of Northern French Caucasian ancestry."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0007457:Caucasian [Population Group]
   753   C0043157:Caucasian [Population Group]
   753   C1556084:French [Population Group]
   753   C1709269:Northern [Spatial Concept]
Processing 00000000.tx.39: Informed consent was obtained from all subjects, and the study was approved by the local ethics committees. 

Phrase: "Informed consent"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0021430:Informed Consent [Regulation or Law]
   861   C1511481:Consent [Functional Concept]
   861   C1522154:Informed [Qualitative Concept]
   861   C1554192:consent [Idea or Concept]
   827 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827 E C0700287:inform [Health Care Activity]
   827 E C1552002:inform [Idea or Concept]

Phrase: "was"

Phrase: "obtained from all subjects,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C1301820:Obtained [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737 E C1706701:Obtain [Activity]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "approved by the local ethics committees."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0085546:Ethics Committee [Professional or Occupational Group]
   753   C0015000:Ethics [Idea or Concept]
   753   C0205276:Local [Spatial Concept]
   753   C0205540:Approved [Qualitative Concept]
   753   C1527243:ethics [Idea or Concept]
   753   C2699414:Committee [Group]
Processing 00000000.tx.40: Genotyping. 

Phrase: "Genotyping."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285573:Genotyping [Laboratory Procedure]
Processing 00000000.tx.41: APM1 SNP genotypes were generated by direct sequencing of PCR products or by the LightCycler technique (Roche Diagnostics, Mannheim, Germany). 

Phrase: "APM1 SNP genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "generated by direct sequencing of PCR products"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0439851:Direct [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C1514468:Products [Entity]
   748   C1553778:Sequencing [Intellectual Product]
   748   C1561491:Sequencing [Functional Concept]
   748   C1947931:Direct [Qualitative Concept]
   748   C3146294:Generated [Activity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "or by the LightCycler technique"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449851:Technique [Functional Concept]

Phrase: "(Roche Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.42: Our genotyping focused on the SNPs that had previously given positive associations with type 2 diabetes. 

Phrase: "Our genotyping"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1285573:Genotyping [Laboratory Procedure]
   966 E C0017431:Genotype [Organism Attribute]

Phrase: "focused on the SNPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0205234:Focused [Spatial Concept]
   753   C1285542:focused [Functional Concept]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "that"

Phrase: "had"

Phrase: "previously given positive associations with type 2 diabetes."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C3645563:Association type [Intellectual Product]
   744   C0004083:Associations [Mental Process]
   711 E C0439849:Association [Qualitative Concept]
   711 E C0596306:Association [Phenomenon or Process]
   711 E C0699792:association [Social Behavior]
Processing 00000000.tx.43: Thus, SNPs 3971 and +712 were genotyped in less than half of the case-control cohort. 

Phrase: "Thus,"

Phrase: "SNPs 3971"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and +"

Phrase: "712"

Phrase: "were"

Phrase: "genotyped in less"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0017431:Genotype [Organism Attribute]

Phrase: "than half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825407:Half [Quantitative Concept]

Phrase: "of the case-control cohort."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0599755:Cohort [Population Group]
   734   C0872128:case control [Health Care Activity]
Processing 00000000.tx.44: Haplotype analyses. 

Phrase: "Haplotype analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.45: Two different methods for haplotype analysis were used, each of which provided different and complementary data. 

Phrase: "Two different methods for haplotype analysis"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C2707190:Analysis method [Laboratory Procedure]
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0449851:Methods [Functional Concept]
   719 E C0871511:METHOD [Intellectual Product]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "each of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1457900:Each [Quantitative Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "complementary data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.46: The program PHASE (30,31) implements a Bayesian statistical method for reconstructing haplotypes from genotype data. 

Phrase: "The program PHASE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "implements"

Phrase: "a Bayesian statistical method for reconstructing haplotypes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1710191:Statistical Method [Research Activity]
   774   C0242198:Bayesian Method [Quantitative Concept]
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "from genotype data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.47: In simulation experiments, the mean error rate with PHASE was approximately half that obtained with the expectation maximization (EM) algorithm. 

Phrase: "In simulation experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "the mean error rate with PHASE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "approximately half"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332232:Approximately [Qualitative Concept]
   861   C2825407:Half [Quantitative Concept]

Phrase: "that"

Phrase: "obtained with the expectation maximization (EM) algorithm."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C2700035:Expectation Maximization Algorithm [Intellectual Product]
   753   C0002045:algorithm [Intellectual Product]
   753   C0679138:Expectation [Idea or Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1553907:algorithm [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.48: The current version (2.0.2) outputs an estimate of the local population recombination rate parameter, . The Haplotype Trend Regression (HTR) program (32) uses the EM algorithm to infer haplotypes. 

Phrase: "The current version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(2.0.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "outputs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709366:Output [Conceptual Entity]

Phrase: "an estimate of the local population recombination rate parameter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0750572:Estimate [Quantitative Concept]

Phrase: "."

Phrase: "The Haplotype Trend Regression (HTR) program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]

Phrase: "(32"

Phrase: ")"

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "the EM algorithm to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C2700035:Expectation Maximization Algorithm [Intellectual Product]
   760   C0002045:algorithm [Intellectual Product]
   760   C1553907:algorithm [Laboratory Procedure]

Phrase: "infer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679201:Infer [Mental Process]

Phrase: "haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.49: A key facility of this program is its ability to test the inferred haplotype probabilities for association with the phenotype (qualitative or quantitative) of interest using a regression-based approach. 

Phrase: "A key facility of this program"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1547538:Facility [Idea or Concept]

Phrase: "is"

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the inferred haplotype probabilities for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033204:Probabilities [Quantitative Concept]

Phrase: "with the phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(qualitative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205556:Qualitative [Qualitative Concept]

Phrase: "or"

Phrase: "quantitative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392762:Quantitative [Quantitative Concept]

Phrase: ")"

Phrase: "of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a regression-based approach."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.50: Empirical P values were derived by permutation using 10,000 replicates. 

Phrase: "Empirical P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C1709380:P-Value [Quantitative Concept]
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "derived by permutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1441547:Derived [Qualitative Concept]
   790   C1882348:Permutation [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "10,000"

Phrase: "replicates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]
Processing 00000000.tx.51: HTR also provides a "sliding window" mode of haplotype analysis to test for associations with haplotypes in a particular region of the gene, such as in the promoter. 

Phrase: "HTR also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0684320:Regression [Pathologic Function]
   812   C0684321:Regression [Mental Process]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a ""sliding window"" mode of haplotype analysis to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1513371:Mode [Functional Concept]
   744   C1705738:Mode [Quantitative Concept]
   744   C2347637:Mode [Quantitative Concept]
   744   C2348146:Mode [Quantitative Concept]

Phrase: "test for associations"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0004083:Associations [Mental Process]
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:test [Intellectual Product]
   756 E C0439849:Association [Qualitative Concept]
   756 E C0596306:Association [Phenomenon or Process]
   756 E C0699792:association [Social Behavior]

Phrase: "with haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "in a particular region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "such as"

Phrase: "in the promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.52: However, this approach raises the nettlesome problem of multiple testing. 

Phrase: "However,"

Phrase: "this approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "raises"

Phrase: "the nettlesome problem of multiple testing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033213:Problem [Finding]
Processing 00000000.tx.53: For each window size of x SNPs, the actual number of windows was given by (8  x) + 1, amounting to a grand total for eight SNPs of 35 windows. 

Phrase: "For each window size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "of x SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "the actual number of windows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "given by"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1442162:GIVEN [Conceptual Entity]
   833   C1550718:given [Idea or Concept]
   833   C3244317:given [Intellectual Product]
   799 E C1947971:Give [Functional Concept]

Phrase: "(8  x) + 1,"

Phrase: "amounting to a grand total"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   726   C1265611:Amount [Quantitative Concept]

Phrase: "for eight SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "of 35 windows."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0557702:windows [Manufactured Object]
   827 E C1272706:Window [Temporal Concept]
   827 E C1704674:Window [Manufactured Object]
Processing 00000000.tx.54: If we then multiply 35 by the average number of common haplotypes in each window (n = 5), we get a conservative Bonferroni correction factor of 175. 

Phrase: "If"

Phrase: "we then multiply 35 by the average number of common haplotypes"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   738   C0018591:Haplotypes [Organism Attribute]
   738   C0205214:Common [Quantitative Concept]
   738   C0237753:*Number [Quantitative Concept]
   738   C0449788:Number [Quantitative Concept]
   738   C1510992:Average [Quantitative Concept]
   738   C1522138:Common [Functional Concept]
   738   C1719797:Multiply [Functional Concept]
   738   C1883708:Then [Temporal Concept]
   738   C2825518:AVERAGE [Quantitative Concept]
   738   C2911648:Multiply [Quantitative Concept]
   738   C3245511:common [Intellectual Product]

Phrase: "in each window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "get"

Phrase: "a conservative Bonferroni correction factor of 175."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0960756:factor A [Organic Chemical]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.55: In an attempt to strike a balance between maximizing the statistical power for detecting haplotype associations and minimizing the level of missing data, subjects with a minimum of six available SNP genotypes (of eight) were included for haplotype estimation. 

Phrase: "In an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516084:Attempt [Event]

Phrase: "strike"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038452:strike [Occupational Activity]

Phrase: "a balance between maximizing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014653:Balance [Organism Function]
   770   C0205415:Balance [Functional Concept]
   770   C0560184:Balance [Finding]

Phrase: "the statistical power for detecting haplotype associations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0814897:Statistical Power [Research Activity]
   748   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "and"

Phrase: "minimizing"

Phrase: "the level of missing data,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "subjects with a minimum of six available SNP genotypes"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   742   C0017431:Genotypes [Organism Attribute]
   742   C0205452:Six [Quantitative Concept]
   742   C0470187:Available [Functional Concept]
           Availability of
   742   C0681850:Subject [Group]
   742   C0752046:SNP [Nucleotide Sequence]
   742   C1524031:Minimum [Qualitative Concept]
   742   C1527094:SNP [Conceptual Entity]
   742   C1550501:{Subject} [Idea or Concept]
   742   C1552614:minimum [Idea or Concept]
   742   C1706203:Subject [Idea or Concept]
   742   C2349001:Subject [Human]
   742   C2697811:Subject [Functional Concept]
   742   C2826545:MINIMUM [Quantitative Concept]

Phrase: "("

Phrase: "of eight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205454:Eight [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "included for haplotype estimation."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0018591:Haplotype [Organism Attribute]
   770   C0332257:included [Functional Concept]
   770   C0680844:estimation [Mental Process]
   770   C0681916:Estimation [Quantitative Concept]
   770   C0750572:Estimation [Quantitative Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.56: A total of 713 case patients and 624 control subjects met this inclusion criterion. 

Phrase: "A total of 713 case patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "624 control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "this inclusion criterion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:Criterion [Intellectual Product]
Processing 00000000.tx.57: Statistical analyses. 

Phrase: "Statistical analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.58: Comparisons of SNP allele and PHASE haplotype frequencies in case patients and control subjects were performed with the 2 test. 

Phrase: "Comparisons of SNP allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "PHASE haplotype frequencies in case patients"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "performed with the 2 test."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.59: Testing SNP alleles for association with quantitative traits was carried out with the Wilcoxon-Kruskal-Wallis test (3032). 

Phrase: "Testing SNP alleles for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Alleles [Gene or Genome]

Phrase: "with quantitative traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599883:traits [Organism Attribute]
   861   C1427926:TRAITS [Gene or Genome]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with the Wilcoxon-Kruskal-Wallis test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C1708614:Kruskal-Wallis Test [Intellectual Product]
   774   C0871608:Wilcoxon Test [Intellectual Product]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]

Phrase: "(3032"

Phrase: ")."
Processing 00000000.tx.60: Pairwise LD was calculated with the GOLD software package (33) from the haplotype counts output by PHASE. 

Phrase: "Pairwise LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "calculated with the GOLD software package"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0013194:Package [Medical Device]
   753   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0037585:Software [Intellectual Product,Manufactured Object]
   753   C0444686:Calculated [Functional Concept]
   753   C1304897:Gold [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C2700580:Package [Manufactured Object]

Phrase: "(33"

Phrase: ")"

Phrase: "from the haplotype counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439157:counts [Quantitative Concept]
   827 E C0750480:Count [Activity]
   827 E C1705566:Count [Quantitative Concept]

Phrase: "output by PHASE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205390:Phase [Temporal Concept]
   790   C1709366:Output [Conceptual Entity]
Processing 00000000.tx.61: Serum adiponectin levels were measured as described previously (25) and corrected for sex, age, and BMI (26). 

Phrase: "Serum adiponectin levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "corrected for sex,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0009253:Sex [Organism Function]
   790   C0036864:Sex [Behavior]
   790   C0079399:sex [Organism Attribute]
   790   C0205202:Corrected [Qualitative Concept]
   790   C1314687:Sex [Finding]
   790   C1522384:sex [Organism Attribute]
   756 E C2349182:Correct [Qualitative Concept]

Phrase: "age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "BMI (26"

Phrase: ")."
Processing 00000000.tx.62: Linkage analyses were carried out using the Genehunter software package (34). 

Phrase: "Linkage analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0796345:linkage analysis [Laboratory Procedure]
   861   C0023745:linkage [Molecular Function]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Genehunter software package"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013194:Package [Medical Device]
   827   C2700580:Package [Manufactured Object]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.63: Type 2 diabetes logarithm of odds (LOD) scores were calculated using the MLS statistic (35) with all ASPs included but weighted by 2/n affected siblings. 

Phrase: "Type 2 diabetes logarithm of odds (LOD)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2986775:Logarithm [Occupational Activity]

Phrase: "scores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:Score [Quantitative Concept]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MLS statistic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C2348149:Statistic [Quantitative Concept]
   861   C2828391:Statistic [Quantitative Concept]
   789 E C0038215:Statistical [Occupation or Discipline]

Phrase: "(35"

Phrase: ")"

Phrase: "with all ASPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206293:Asp [Reptile]
  1000   C3541260:ASP [Gene or Genome]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "but"

Phrase: "weighted by 2/n affected siblings."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0005910:weighted [Organism Attribute]
   753   C0037047:Siblings [Family Group]
   753   C0043100:weighted [Quantitative Concept]
   753   C0392760:Affected [Functional Concept]
   753   C1305866:weighted [Diagnostic Procedure]
   753   C1314939:Affected [Functional Concept]
   719 E C1611273:Sibling [Intellectual Product]
   719 E C1705104:Weight [Idea or Concept]
Processing 00000000.tx.64: LOD scores for adiponectin levels were carried out using the EM Haseman-Elston regression statistic (36) with only the first ASP from each sibship included in the analysis (34,36). 

Phrase: "LOD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986775:Logarithm [Occupational Activity]

Phrase: "scores for adiponectin levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C0449820:Score [Quantitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the EM Haseman-Elston regression statistic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C2348149:Statistic [Quantitative Concept]
   799   C2828391:Statistic [Quantitative Concept]
   727 E C0038215:Statistical [Occupation or Discipline]

Phrase: "(36"

Phrase: ")"

Phrase: "with only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the first ASP from each sibship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709450:Pair [Qualitative Concept]

Phrase: "included in the analysis"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0332257:included [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "(34,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.65: The information content for all microsatellite markers in the 3q27-qter region exceeded 0.85 (24). 

Phrase: "The information content for all microsatellite markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
   748   C1533716:Information [Idea or Concept]

Phrase: "in the 3q27-qter region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "exceeded"

Phrase: "0.85"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.66: Association with the evidence for linkage. 

Phrase: "Association with the evidence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "for linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]
Processing 00000000.tx.67: For each SNP, we tested both alleles for association with the evidence for linkage (AEL). 

Phrase: "For each SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "both alleles for association with the evidence for linkage (AEL)."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0002085:Alleles [Gene or Genome]
   742   C0004083:Association [Mental Process]
   742   C0023745:linkage [Molecular Function]
   742   C0238767:Both [Spatial Concept]
   742   C0332120:Evidence [Functional Concept]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]
   742   C1706086:Both [Qualitative Concept]
Processing 00000000.tx.68: Following a modified version of the method of Horikawa et al. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a modified version of the method of Horikawa et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0333052:Version [Functional Concept]
   739   C2607870:Version [Spatial Concept]
Processing 00000000.tx.69: (37), we postulated that if allele 1 (the major allele) was the predisposing allele, then ASPs that contribute to the linkage would have concordant 1x-1x genotypes, i.e., 1/1-1/1 or 1/2-1/2 genotypes. 

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "postulated"

Phrase: "that"

Phrase: "if"

Phrase: "allele 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "("

Phrase: "the major allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "the predisposing allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "then ASPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206293:Asp [Reptile]
   861   C3541260:ASP [Gene or Genome]

Phrase: "that"

Phrase: "contribute to the linkage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0023745:linkage [Molecular Function]
   770   C1880177:Contribute [Activity]

Phrase: "would"

Phrase: "have"

Phrase: "concordant 1x-1x genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "1/1-1/1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "or"

Phrase: "1/2-1/2 genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.70: Similarly, if allele 2 (the minor allele) were the risk allele, then ASPs would have concordant x2-x2 genotypes, i.e., 1/2-1/2 or 2/2-2/2 genotypes. 

Phrase: "Similarly,"

Phrase: "if"

Phrase: "allele 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "("

Phrase: "the minor allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "the risk allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "then ASPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206293:Asp [Reptile]
   861   C3541260:ASP [Gene or Genome]

Phrase: "would"

Phrase: "have"

Phrase: "concordant x2-x2 genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "1/2-1/2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0580272:1/2 [Intellectual Product]
   861   C1519043:1-2 [Research Activity]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "or"

Phrase: "2/2-2/2 genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.71: This is equivalent to a dominant model of inheritance. 

Phrase: "This"

Phrase: "is"

Phrase: "equivalent to a dominant model of inheritance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205163:Equivalent [Qualitative Concept]
   748   C0439185:equivalent [Quantitative Concept]
Processing 00000000.tx.72: Accordingly, a set of ASPs with concordant genotypes 1/1-1/1 or 1/2-1/2 and a set of ASPs with concordant genotypes 1/2-1/2 or 2/2-2/2 were identified. 

Phrase: "Accordingly,"

Phrase: "a set of ASPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "with concordant genotypes 1/1-1/1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0017431:Genotypes [Organism Attribute]
   727   C0680240:concordance [Social Behavior]

Phrase: "or"

Phrase: "1/2-1/2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0580272:1/2 [Intellectual Product]
   861   C1519043:1-2 [Research Activity]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "a set of ASPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "with concordant genotypes 1/2-1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0017431:Genotypes [Organism Attribute]
   727   C0680240:concordance [Social Behavior]

Phrase: "or"

Phrase: "2/2-2/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "were"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.73: Expected identical-by-descent (ibd) allele-sharing proportions under the null hypothesis of no AEL were calculated for each concordant ASP set conditional on allele frequency, concordant genotype, and the estimated ibd sharing distribution for peak linkage marker D3S1580 (24). 

Phrase: "Expected identical-by-descent (ibd)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205280:Identical [Qualitative Concept]
   812   C0680043:descent [Family Group]
   812   C1517001:Expected [Idea or Concept]

Phrase: "allele-sharing proportions under the null hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1709707:Proportion [Quantitative Concept]

Phrase: "of no AEL"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0004083:Association [Mental Process]
   793   C0023745:linkage [Molecular Function]
   793   C0332120:Evidence [Functional Concept]
   793   C0332285:Of [Spatial Concept]
   793   C0439849:Association [Qualitative Concept]
   793   C0596306:Association [Phenomenon or Process]
   793   C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "calculated for each concordant ASP set conditional"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   742   C0036849:Set [Mental Process]
   742   C0037047:Sibling [Family Group]
   742   C0392760:Affected [Functional Concept]
   742   C0444686:Calculated [Functional Concept]
   742   C1314939:Affected [Functional Concept]
   742   C1441506:Calculated [Activity]
   742   C1442518:Set [Functional Concept]
   742   C1443182:Calculated [Laboratory Procedure]
   742   C1611273:Sibling [Intellectual Product]
   742   C1701901:Conditional [Qualitative Concept]
   742   C1705195:Set [Conceptual Entity]
   742   C1709450:Pair [Qualitative Concept]
   742   C1963686:Conditional [Functional Concept]

Phrase: "on allele frequency,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0017270:Allele Frequency [Quantitative Concept]
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "concordant genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "the estimated ibd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205280:Identical [Qualitative Concept]
   804   C0680043:descent [Family Group]
   804   C0750572:Estimated [Quantitative Concept]

Phrase: "sharing distribution for peak linkage marker D3S1580"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.74: The probability of an ASP having the concordant genotype 1/1 or 2/2 is given by p4s or q4s, respectively, where p and q are the frequencies of alleles 1 and 2 and s is the number of alleles shared ibd. 

Phrase: "The probability of an ASP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033204:Probability [Quantitative Concept]

Phrase: "having"

Phrase: "the concordant genotype 1/1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017431:Genotype [Organism Attribute]
   741   C0680240:concordance [Social Behavior]

Phrase: "or"

Phrase: "2/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "is"

Phrase: "given by p4s"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]

Phrase: "or"

Phrase: "q4s,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1275555:Q4S [Temporal Concept]

Phrase: "respectively,"

Phrase: "where p"

Phrase: "and"

Phrase: "q"

Phrase: "are"

Phrase: "the frequencies of alleles 1"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   781   C0017270:Frequencies, Allele [Quantitative Concept]
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and s"

Phrase: "is"

Phrase: "the number of alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "shared"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237876:shared [Social Behavior]
  1000   C1522138:Shared [Functional Concept]

Phrase: "ibd."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.75: The probability of an ASP having the concordant genotype 1/2 given 0, 1, and 2 alleles shared ibd is (2pq)2, pq, and 2pq, respectively. 

Phrase: "The probability of an ASP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033204:Probability [Quantitative Concept]

Phrase: "having"

Phrase: "the concordant genotype 1/2 given 0,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0017431:Genotype [Organism Attribute]
   727   C0680240:concordance [Social Behavior]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "shared"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237876:shared [Social Behavior]
  1000   C1522138:Shared [Functional Concept]

Phrase: "ibd is (2pq"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205280:Identical [Qualitative Concept]

Phrase: ")"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "pq,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987314:PQ [Qualitative Concept]

Phrase: "and"

Phrase: "2pq,"

Phrase: "respectively."
Processing 00000000.tx.76: Observed ibd sharing proportions were determined by counting the number of concordant ASPs in each ibd class, as indicated by the estimated ibd sharing status of the ASP. 

Phrase: "Observed ibd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205280:Identical [Qualitative Concept]
   812   C0680043:descent [Family Group]
   812   C1441672:Observed [Functional Concept]

Phrase: "sharing proportions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709707:Proportion [Quantitative Concept]
   777 E C0205351:Proportional [Qualitative Concept]

Phrase: "were"

Phrase: "determined by counting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]

Phrase: "the number of concordant ASPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "in each ibd"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0150312:In [Quantitative Concept]
   804   C0205280:Identical [Qualitative Concept]
   804   C0332285:In [Spatial Concept]
   804   C0680043:descent [Family Group]

Phrase: "class,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "as"

Phrase: "indicated by the estimated ibd"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205280:Identical [Qualitative Concept]
   748   C0680043:descent [Family Group]
   748   C0750572:Estimated [Quantitative Concept]
   748   C1444656:Indicated [Finding]

Phrase: "sharing status of the ASP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.77: An observed allele-sharing proportion that is higher than the null level presents evidence of AEL. 

Phrase: "An observed allele-sharing proportion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1709707:Proportion [Quantitative Concept]
   741 E C0205351:Proportional [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "higher than the null level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "evidence of AEL."
Processing 00000000.tx.78: The statistical significance of the difference between the observed and expected allele sharing was determined by gene-dropping simulation, preserving the ibd status of ASPs, as described previously (29,37). 

Phrase: "The statistical significance of the difference"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   790   C1709380:Statistical Significance [Quantitative Concept]
   753   C0038215:Statistical [Occupation or Discipline]
   753   C0750502:Significance [Idea or Concept]

Phrase: "between the observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "expected allele sharing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0237876:Sharing [Social Behavior]

Phrase: "was"

Phrase: "determined by gene-dropping simulation,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0017337:Gene [Gene or Genome]
   760   C0679083:Simulation [Research Activity]
   760   C1705648:Dropping [Activity]
   726 E C1321095:Drop [Quantitative Concept]
   726 E C2347093:Drop [Quantitative Concept]
   726 E C2348338:Drop [Quantitative Concept]

Phrase: "preserving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0728887:Preserving [Functional Concept]

Phrase: "the ibd"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205280:Identical [Qualitative Concept]
   812   C0680043:descent [Family Group]

Phrase: "status of ASPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449438:Status [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(29,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.79: Empirical P values were all >0.05 with 100 simulations.  

Phrase: "Empirical P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C1709380:P-Value [Quantitative Concept]
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "all >0.05 with 100 simulations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0444868:All [Quantitative Concept]
   753   C0679083:simulations [Research Activity]
   753   C3539085:All [Idea or Concept]
Processing 00000000.tx.80: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  We have performed a case-control genetic association study of APM1 genetic variants in the French Caucasian population, with the aim of replicating the results of a previous report indicating that SNPs in the APM1 promoter region are associated with type 2 diabetes (26). 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a case-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "genetic association study of APM1 genetic variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C2717878:Study, Genetic Association [Molecular Biology Research Technique]
   774   C2827447:Genetic Study [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "in the French Caucasian population,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "with the aim"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1947946:Aim [Idea or Concept]
  1000   C2948600:Aim [Pharmacologic Substance]
  1000   C3540471:AIM [Gene or Genome]
  1000   C3540472:AIM [Functional Concept]

Phrase: "of replicating"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicating [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: "the results of a previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "indicating"

Phrase: "that SNPs in the APM1 promoter region"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   742   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0032529:polymorphisms [Genetic Function]
   742   C0037179:Single [Population Group]
   742   C0087136:single [Finding]
   742   C0205171:Single [Quantitative Concept]
   708 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.81: The genotype distribution was in accordance with Hardy-Weinberg equilibrium for all SNPs (data not shown). 

Phrase: "The genotype distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "was in accordance with Hardy-Weinberg equilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0014653:Equilibrium [Organism Function]
   748   C0043194:WAS [Disease or Syndrome]
   748   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1421478:WAS [Gene or Genome]
   748   C1547026:Equilibrium [Quantitative Concept]

Phrase: "for all SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: There were no significant differences in SNP allele or haplotype frequencies between men and women, and no additional associations were uncovered by stratifying for sex (data not shown). 

Phrase: "There"

Phrase: "were"

Phrase: "no significant differences in SNP allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "haplotype frequencies between men"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   770   C0439603:Frequencies [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "women,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "and"

Phrase: "no additional associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0004083:Associations [Mental Process]
   827 E C0439849:Association [Qualitative Concept]
   827 E C0596306:Association [Phenomenon or Process]
   827 E C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "uncovered by stratifying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205363:stratifying [Qualitative Concept]
   790   C0439845:Uncovered [Functional Concept]

Phrase: "for sex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.83: Of the 10 common SNPs in the APM1 gene (25,26), SNP pairs +45 and +349 and +712 and +2019 are in complete LD (d2 = 1) (26), and so data are presented only for the eight nonredundant SNPs shown in Table 1. 

Phrase: "Of the 10 common SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   884   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0032529:polymorphisms [Genetic Function]
   804   C0037179:Single [Population Group]
   804   C0087136:single [Finding]
   804   C0205171:Single [Quantitative Concept]
   771 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in the APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "(25,"

Phrase: "26"

Phrase: ")"

Phrase: ","

Phrase: "SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "+45"

Phrase: "and +"

Phrase: "349"

Phrase: "and +"

Phrase: "712"

Phrase: "and +"

Phrase: "2019"

Phrase: "are in complete LD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   806   C1880153:Complete Linkage [Research Activity]
   760   C0023745:linkage [Molecular Function]
   760   C0205197:Complete [Qualitative Concept]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C0725685:COMPLEAT [Food]
   760   C1551058:Are [Quantitative Concept]

Phrase: "(d2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414052:D2 [Gene or Genome]
  1000   C1415944:D2 [Gene or Genome]

Phrase: "= 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "so data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "only for the eight nonredundant SNPs"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   800   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0032529:polymorphisms [Genetic Function]
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Only [Quantitative Concept]
           Single
   744   C0205454:Eight [Quantitative Concept]
   744   C1720467:Only [Intellectual Product]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "shown in Table 1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.84: The G allele of SNP 11426 in the APM1 promoter was the only variant nominally associated with type 2 diabetes (odds ratio [OR] 1.44 [CI 1.041.98]; P = 0.03), a result that was obtained with 551 case patients and 551 control subjects. 

Phrase: "The G allele of SNP 11426"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "in the APM1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "the only variant nominally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205171:Only [Quantitative Concept]
   827   C0205419:Variant [Qualitative Concept]
   827   C1720467:Only [Intellectual Product]

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(odds ratio [OR] 1.44"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "[CI 1.041.98"

Phrase: "]"

Phrase: "; P = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "that"

Phrase: "was"

Phrase: "obtained with 551 case patients"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0868928:Case [Functional Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]
   726 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "551 control subjects."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]
Processing 00000000.tx.85: We did not find evidence for association of SNP 11426 with the homeostasis model assessment of insulin resistance index (38) or with adiponectin levels in either type 2 diabetic patients or normoglycemic control subjects (data not shown). 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "evidence for association of SNP 11426"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with the homeostasis model assessment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1829779:Homeostasis model assessment [Laboratory Procedure]
  1000   C1830060:Homeostasis model assessment [Clinical Attribute]
   827   C0019868:Homeostasis [Biologic Function]
   827   C1261322:Assessment [Health Care Activity]
   827   C1516048:Assessment [Activity]
   827   C3161035:Model [Intellectual Product]

Phrase: "of insulin resistance index"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0807745:Resistance.index [Clinical Attribute]
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]
   734   C0021655:Insulin Resistance [Pathologic Function]
   734   C2700570:INSULIN RESISTANCE [Gene or Genome]

Phrase: "(38"

Phrase: ")"

Phrase: "or with adiponectin levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in either type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "or"

Phrase: "normoglycemic control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.86: View this table: [in this window] [in a new window]  TABLE 1 APM1 SNP allele frequencies in type 2 diabetic patients and normoglycemic control subjects  In haplotype analyses, an important factor to consider is that of missing genotype data, which has a detrimental effect on the accuracy of inferred genotypes. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 APM1 SNP allele frequencies in type 2 diabetic patients"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   756   C0017270:Frequencies, Allele [Quantitative Concept]
   738   C0439603:Frequencies [Temporal Concept]
   704 E C0376249:frequency [Quantitative Concept]
   704 E C0871396:Frequency [Quantitative Concept]
   704 E C1561548:Frequency [Qualitative Concept]
   704 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "normoglycemic control subjects  In haplotype analyses,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "an important factor to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "consider"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "is"

Phrase: "that of missing genotype data,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0017431:Genotype [Organism Attribute]
   760   C1511726:Data [Idea or Concept]
   760   C1551393:Missing [Idea or Concept]
   760   C1705492:Missing [Qualitative Concept]
   760   C3245479:data [Medical Device]
   760   C3272743:MISSING [Qualitative Concept]

Phrase: "which"

Phrase: "has"

Phrase: "a detrimental effect on the accuracy of inferred genotypes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.87: As shown in Table 1, the degree of missing genotype data varied across the eight SNPs analyzed. 

Phrase: "As"

Phrase: "shown in Table 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "the degree of missing genotype data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]

Phrase: "varied across the eight SNPs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0205454:Eight [Quantitative Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.88: Thus, in an attempt to strike a balance between maximizing the statistical power for detecting haplotype associations and minimizing the level of missing data, subjects with a minimum of six available SNP genotypes (of a total of eight) were included for haplotype estimation. 

Phrase: "Thus,"

Phrase: "in an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516084:Attempt [Event]

Phrase: "strike"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038452:strike [Occupational Activity]

Phrase: "a balance between maximizing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014653:Balance [Organism Function]
   770   C0205415:Balance [Functional Concept]
   770   C0560184:Balance [Finding]

Phrase: "the statistical power for detecting haplotype associations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0814897:Statistical Power [Research Activity]
   748   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "and"

Phrase: "minimizing"

Phrase: "the level of missing data,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "subjects with a minimum of six available SNP genotypes"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   742   C0017431:Genotypes [Organism Attribute]
   742   C0205452:Six [Quantitative Concept]
   742   C0470187:Available [Functional Concept]
           Availability of
   742   C0681850:Subject [Group]
   742   C0752046:SNP [Nucleotide Sequence]
   742   C1524031:Minimum [Qualitative Concept]
   742   C1527094:SNP [Conceptual Entity]
   742   C1550501:{Subject} [Idea or Concept]
   742   C1552614:minimum [Idea or Concept]
   742   C1706203:Subject [Idea or Concept]
   742   C2349001:Subject [Human]
   742   C2697811:Subject [Functional Concept]
   742   C2826545:MINIMUM [Quantitative Concept]

Phrase: "("

Phrase: "of a total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "of eight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205454:Eight [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "included for haplotype estimation."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0018591:Haplotype [Organism Attribute]
   770   C0332257:included [Functional Concept]
   770   C0680844:estimation [Mental Process]
   770   C0681916:Estimation [Quantitative Concept]
   770   C0750572:Estimation [Quantitative Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.89: The haplotype frequency distribution of case patients and control subjects inferred by PHASE is shown in Table 2. 

Phrase: "The haplotype frequency distribution of case patients"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0237580:Frequency Distribution [Quantitative Concept]
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0520511:distribution [Idea or Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1704711:Distribution [Functional Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "inferred by PHASE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205390:Phase [Temporal Concept]
   790   C0679201:Inferred [Mental Process]
   790   C3245504:inferred [Idea or Concept]

Phrase: "is"

Phrase: "shown in Table 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.90: The average posterior probability of a haplotype pair across the entire dataset was moderate (0.68  0.23). 

Phrase: "The average posterior probability of a haplotype pair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033204:Probability [Quantitative Concept]

Phrase: "across the entire dataset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150098:Data Set [Intellectual Product]
   861   C1706233:Dataset [Intellectual Product]

Phrase: "was"

Phrase: "moderate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]

Phrase: "(0.68  0.23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450348:23 [Quantitative Concept]
   812   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: The most common haplotype spanning the APM1 gene (1-1-1-1-1-1-1-1) was associated with normoglycemia, both with a simple 2 analysis of the haplotype frequencies output by PHASE (OR 0.78 [95% CI 0.640.96]; P = 0.017) and with the HTR software (P = 0.008). 

Phrase: "The most common haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotype [Organism Attribute]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "(1-1-1-1-1-1-1-1"

Phrase: ")"

Phrase: "was"

Phrase: "associated with normoglycemia,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718   C0580545:Normoglycaemic [Finding]

Phrase: "both with a simple 2 analysis of the haplotype frequencies"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0018591:Haplotype [Organism Attribute]
   739   C0205352:Simple [Qualitative Concept]
   739   C0238767:Both [Spatial Concept]
   739   C0439603:Frequencies [Temporal Concept]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
   739   C1706086:Both [Qualitative Concept]
   706 E C0376249:frequency [Quantitative Concept]
   706 E C0871396:Frequency [Quantitative Concept]
   706 E C1561548:Frequency [Qualitative Concept]
   706 E C1705502:Frequency [Quantitative Concept]

Phrase: "output by PHASE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205390:Phase [Temporal Concept]
   790   C1709366:Output [Conceptual Entity]

Phrase: "(OR 0.78"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "[95% CI 0.640.96"

Phrase: "]"

Phrase: "; P = 0.017"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and with the HTR software"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0018591:Haplotype [Organism Attribute]
   748   C0037585:Software [Intellectual Product,Manufactured Object]
   748   C0684320:Regression [Pathologic Function]
   748   C0684321:Regression [Mental Process]
   748   C1515981:And [Idea or Concept]
   748   C1521798:trend [Temporal Concept]

Phrase: "(P = 0.008"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.92: A "sliding window" analysis of haplotype associations was also carried out with the HTR software. 

Phrase: "A ""sliding window"" analysis of haplotype associations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with the HTR software."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0018591:Haplotype [Organism Attribute]
   748   C0037585:Software [Intellectual Product,Manufactured Object]
   748   C0439787:Out [Spatial Concept]
   748   C0684320:Regression [Pathologic Function]
   748   C0684321:Regression [Mental Process]
   748   C0849355:Out [Qualitative Concept]
   748   C1521798:trend [Temporal Concept]
Processing 00000000.tx.93: The haplotypes 1-1-1, 1-1-1-1, and 1-1-1-1-1 all gave empirical P values 0.0001, indicating strong association with normoglycemia (Table 3). 

Phrase: "The haplotypes 1-1-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]

Phrase: "1-1-1-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "1-1-1-1-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2827734:1+ [Quantitative Concept]
   804   C2981698:1+ [Classification]

Phrase: "all"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "empirical P values 0.0001,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C1709380:P-Value [Quantitative Concept]
   804   C0042295:Values [Qualitative Concept]
   804   C1880496:Empirical [Qualitative Concept]
   771 E C1522609:Value [Quantitative Concept]

Phrase: "indicating"

Phrase: "strong association with normoglycemia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: These results were still significant after a conservative Bonferroni correction for the number of tests carried out in the sliding window analyses. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "still significant after a conservative Bonferroni correction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0237881:significant [Quantitative Concept]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]

Phrase: "for the number of tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in the sliding window analyses."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   753   C0332246:Sliding [Functional Concept]
   753   C0439787:Out [Spatial Concept]
   753   C0557702:Window [Manufactured Object]
   753   C0849355:Out [Qualitative Concept]
   753   C1272706:Window [Temporal Concept]
   753   C1704674:Window [Manufactured Object]
   719   C0002778:Analysis [Laboratory Procedure]
   719 E C0444330:Slide [Research Device]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]
   719 E C1705201:Slide [Manufactured Object]
Processing 00000000.tx.95: We did not find evidence for association of any haplotype with the homeostasis model assessment of insulin resistance index (38) or with adiponectin levels in either type 2 diabetic patients or normoglycemic control subjects (data not shown). 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "evidence for association of any haplotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with the homeostasis model assessment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1829779:Homeostasis model assessment [Laboratory Procedure]
  1000   C1830060:Homeostasis model assessment [Clinical Attribute]
   827   C0019868:Homeostasis [Biologic Function]
   827   C1261322:Assessment [Health Care Activity]
   827   C1516048:Assessment [Activity]
   827   C3161035:Model [Intellectual Product]

Phrase: "of insulin resistance index"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0807745:Resistance.index [Clinical Attribute]
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]
   734   C0021655:Insulin Resistance [Pathologic Function]
   734   C2700570:INSULIN RESISTANCE [Gene or Genome]

Phrase: "(38"

Phrase: ")"

Phrase: "or with adiponectin levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in either type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "or"

Phrase: "normoglycemic control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: As a group, the pooled rare haplotypes were weakly associated with type 2 diabetes by 2 analysis (OR 1.19 [95% CI 1.011.40]; P = 0.03). 

Phrase: "As a group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "the pooled rare haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "weakly"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "by 2 analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "(OR 1.19"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "[95% CI 1.011.40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0444894:CI 40 [Intellectual Product]
   804   C0439509:/40 [Temporal Concept]

Phrase: "]"

Phrase: "; P = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.97: The frequency of the "1-2" promoter haplotype previously reported to be associated with type 2 diabetes (26) was higher in type 2 diabetic patients than in normoglycemic control subjects (27.1 vs. 24.4%), but the difference was not statistically significant in this study (P = 0.11). 

Phrase: "The frequency of the ""1-2"" promoter haplotype previously"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0376249:frequency [Quantitative Concept]
   742   C0439603:Frequency [Temporal Concept]
   742   C0871396:Frequency [Quantitative Concept]
   742   C1561548:Frequency [Qualitative Concept]
   742   C1705502:Frequency [Quantitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(26"

Phrase: ")"

Phrase: "was"

Phrase: "higher in type 2 diabetic patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "in normoglycemic control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "(27.1"

Phrase: "vs. 24.4%"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "not statistically significant in this study"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0237881:statistically significant [Quantitative Concept]
           significant
   783   C1273937:Not significant [Finding]
   753   C0038215:Statistically [Occupation or Discipline]
   753   C0750502:Significant [Idea or Concept]
   753   C1546944:Significant [Qualitative Concept]
   718 E C1709380:Statistical Significance [Quantitative Concept]

Phrase: "(P = 0.11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0069877:P 11 [Organic Chemical,Pharmacologic Substance]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.98: View this table: [in this window] [in a new window]  TABLE 2 APM1 haplotype distribution in case and control subjects  View this table: [in this window] [in a new window]  TABLE 3 APM1 haplotypes associated with normoglycemia in a "sliding window" analysis  We compared the extent of pairwise LD across the set of eight nonredundant APM1 SNPs, as indicated by the metrics D' and d2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 APM1 haplotype distribution in case"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3 APM1 haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]

Phrase: "associated with normoglycemia"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718   C0580545:Normoglycaemic [Finding]

Phrase: "in a ""sliding window"" analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "We"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the extent of pairwise LD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439792:Extent [Spatial Concept]

Phrase: "across the set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "of eight nonredundant APM1 SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   799   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0032529:polymorphisms [Genetic Function]
   799   C0037179:Single [Population Group]
   799   C0087136:single [Finding]
   799   C0205171:Single [Quantitative Concept]
   766 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "as"

Phrase: "indicated by the metrics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0699680:metrics [Organic Chemical,Pharmacologic Substance]
   770   C1444656:Indicated [Finding]

Phrase: "D'"

Phrase: "and"

Phrase: "d2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414052:D2 [Gene or Genome]
  1000   C1415944:D2 [Gene or Genome]
Processing 00000000.tx.99: The median of all D' values was 0.89, indicating high LD, as reported previously (26), but the median d2 value was only 0.03, indicating a low level of LD across the APM1 gene (Table 4). 

Phrase: "The median of all D' values"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0549183:Median [Spatial Concept]
   753   C0876920:Median [Quantitative Concept]
   753   C2347635:Median [Quantitative Concept]
   753   C2348144:Median [Quantitative Concept]
   753   C2939193:Median [Spatial Concept]

Phrase: "was"

Phrase: "0.89,"

Phrase: "indicating"

Phrase: "high LD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the median d2 value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "only 0.03,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205171:Only [Quantitative Concept]
   827   C1720467:Only [Intellectual Product]

Phrase: "indicating"

Phrase: "a low level of LD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205251:low [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1299352:Low [Qualitative Concept]
   753   C1547707:Level [Geographic Area]
   753   C1550472:low [Idea or Concept]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "across the APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.100: D' is scaled to be independent of allele frequency and therefore is typically higher than d2 (39), but even so, the level of LD indicated by the two metrics seemed contradictory. 

Phrase: "D'"

Phrase: "is"

Phrase: "scaled"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0175659:Scale [Medical Device]
   966   C0349674:Scale [Intellectual Product]
   966   C1947916:Scale [Activity]
   966   C3536777:Scale [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be independent of allele frequency"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0017270:Allele Frequency [Quantitative Concept]
   806   C0332291:Independent of [Functional Concept]
   760   C0002085:Allele [Gene or Genome]
   760   C0085862:Independent [Idea or Concept]
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1299583:Independent [Finding]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "and"

Phrase: "therefore"

Phrase: "is"

Phrase: "typically higher than d2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "(39"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "even so,"

Phrase: "the level of LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "indicated by the two metrics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205448:Two [Quantitative Concept]
   760   C0699680:metrics [Organic Chemical,Pharmacologic Substance]
   760   C1444656:Indicated [Finding]

Phrase: "seemed"

Phrase: "contradictory."
Processing 00000000.tx.101: To investigate this further, we reexamined the haplotype structure of the APM1 gene. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "this further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "we"

Phrase: "reexamined"

Phrase: "the haplotype structure of the APM1 gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C1517495:Gene Structure [Gene or Genome]
   748   C0678594:Structure [Spatial Concept]
   738 E C0017366:Structural gene [Gene or Genome]
Processing 00000000.tx.102: Table 2 shows that six common (frequency 5%) haplotypes spanning the gene were identified, accounting for 68% of control chromosomes. 

Phrase: "Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that six common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205214:Common [Quantitative Concept]
   861   C1522138:Common [Functional Concept]
   861   C3245511:common [Intellectual Product]

Phrase: "(frequency 5%"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "accounting for 68% of control chromosomes."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0000938:Accounting [Occupational Activity]
   753   C0008633:Chromosomes [Cell Component]
   753   C0243148:control [Qualitative Concept]
   753   C0450387:68 [Intellectual Product]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C1551359:account [Idea or Concept]
   719 E C2741673:Account # [Clinical Attribute]
   719 E C2981730:Account [Classification]
Processing 00000000.tx.103: This is indicative of a higher level of haplotype diversity than that reported in the majority of previous candidate gene studies, where three to six common haplotypes accounted for 8090% of chromosomes (4042). 

Phrase: "This"

Phrase: "is"

Phrase: "indicative of a higher level of haplotype diversity"

Phrase: "than that"

Phrase: "reported in the majority of previous candidate gene studies,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   764   C1273305:Gene studies [Laboratory Procedure]
   764   C1332838:Candidate Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0205156:Previous [Temporal Concept]
   742   C0680220:majority [Social Behavior]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C0947630:studies [Laboratory Procedure]
   742   C1552607:previous [Temporal Concept]
   742   C3496591:Reported [Clinical Attribute]
   728   C1317750:Study report [Intellectual Product]
   728   C1831145:Study report [Clinical Attribute]
   708 E C0557651:Study [Manufactured Object]
   708 E C2603343:Study [Research Activity]
   708 E C3273238:Report [Intellectual Product]

Phrase: "where three to six common haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0018591:Haplotypes [Organism Attribute]

Phrase: "accounted for 8090% of chromosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008633:Chromosomes [Cell Component]
   726   C1551359:account [Idea or Concept]
   726   C2741673:Account # [Clinical Attribute]
   726   C2981730:Account [Classification]

Phrase: "(4042"

Phrase: ")."
Processing 00000000.tx.104: From the APM1 haplotype data, the population recombination rate parameter was estimated by PHASE to be 0.092, >2 orders of magnitude higher than the average value of 0.0004 (43), indicating that the APM1 gene is a locus of high recombination and, therefore, of low LD. 

Phrase: "From the APM1 haplotype data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "the population recombination rate parameter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C2350001:Population Parameter [Quantitative Concept]
           Parameter
   812   C0549193:Parameter [Spatial Concept]
   812   C1704769:Parameter [Conceptual Entity]

Phrase: "was"

Phrase: "estimated by PHASE to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205390:Phase [Temporal Concept]
   770   C0750572:Estimated [Quantitative Concept]

Phrase: "be"

Phrase: "0.092,"

Phrase: ">2 orders of magnitude"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   770   C3244315:orders [Intellectual Product]
   737 E C1705175:Order [Intellectual Product]
   737 E C1705176:Order [Qualitative Concept]
   737 E C1705177:Order [Classification]
   737 E C1705178:Order [Activity]
   737 E C1882348:Order [Qualitative Concept]

Phrase: "higher than the average value of 0.0004"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "(43"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "a locus of high recombination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: ","

Phrase: "therefore,"

Phrase: "of low LD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]
Processing 00000000.tx.105: We tested the APM1 SNPs for AEL of type 2 diabetes to 3q27, using a modified version of the linkage partitioning method described by Horikawa et al. 

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the APM1 SNPs for AEL"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   770   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   751   C1883037:Single Linkage [Research Activity]
   736   C0004083:Association [Mental Process]
   736   C0023745:linkage [Molecular Function]
   736   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0032529:polymorphisms [Genetic Function]
   736   C0037179:Single [Population Group]
   736   C0087136:single [Finding]
   736   C0205171:Single [Quantitative Concept]
   736   C0332120:Evidence [Functional Concept]
   736   C0439849:Association [Qualitative Concept]
   736   C0596306:Association [Phenomenon or Process]
   736   C0699792:association [Social Behavior]
   736   C1540187:APM1 [Gene or Genome]
   736   C2986675:APM1 [Gene or Genome]
   703 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "of type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "to 3q27,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521326:3q27 [Cell Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a modified version of the linkage partitioning method"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0333052:Version [Functional Concept]
   744   C2607870:Version [Spatial Concept]

Phrase: "described by Horikawa et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.106: (37). 

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.107: Briefly, this involved calculating the expected and observed allele-sharing proportions for ASPs with concordant genotypes, conditional on the estimated allele-sharing distribution of the original genome scan dataset (24). 

Phrase: "Briefly,"

Phrase: "this involved calculating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1441506:Calculating [Activity]

Phrase: "the expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "and"

Phrase: "observed allele-sharing proportions for ASPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1709707:Proportion [Quantitative Concept]

Phrase: "with concordant genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "conditional on the estimated allele-sharing distribution of the original genome scan dataset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C1701901:Conditional [Qualitative Concept]
   735   C1963686:Conditional [Functional Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.108: The results, shown in Table 5, indicate that under the null hypothesis of no AEL, every one of the APM1 SNP alleles would be expected to exhibit an allele-sharing proportion that is higher than the original linkage result. 

Phrase: "The results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown in Table 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "indicate"

Phrase: "that under the null hypothesis of no AEL,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   749   C0332120:Evidence of [Functional Concept]
           Evidence
   735   C0004083:Association [Mental Process]
   735   C0023745:linkage [Molecular Function]
   735   C0439849:Association [Qualitative Concept]
   735   C0456148:Null [Quantitative Concept]
   735   C0596306:Association [Phenomenon or Process]
   735   C0699792:association [Social Behavior]
   735   C1512571:Hypothesis [Idea or Concept]

Phrase: "every one of the APM1 SNP alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "an allele-sharing proportion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709707:Proportion [Quantitative Concept]
   755 E C0205351:Proportional [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "higher than the original linkage result."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.109: This reflects the inherent bias toward linkage associated with ASP subsets with concordant genotypes. 

Phrase: "This"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the inherent bias toward linkage"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0242568:Bias [Idea or Concept]
   760   C1504315:Bias [Bird]
   726 E C1061346:Bia [Eukaryote]
   726 E C1704746:BIA [Diagnostic Procedure]

Phrase: "associated with ASP subsets"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0037047:Sibling [Family Group]
   753   C0392760:Affected [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   753   C1611273:Sibling [Intellectual Product]
   753   C1709450:Pair [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719   C1515021:Subset [Classification]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "with concordant genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.110: It is clear that none of the APM1 SNP alleles exhibited an allele-sharing proportion that was higher than the null value. 

Phrase: "It"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "none of the APM1 SNP alleles"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0002085:Alleles [Gene or Genome]
   753   C0456148:None [Quantitative Concept]
   753   C0549184:None [Quantitative Concept]
   753   C0752046:SNP [Nucleotide Sequence]
   753   C1527094:SNP [Conceptual Entity]
   753   C1540187:APM1 [Gene or Genome]
   753   C2986675:APM1 [Gene or Genome]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "an allele-sharing proportion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709707:Proportion [Quantitative Concept]
   755 E C0205351:Proportional [Qualitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "higher than the null value."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.111: Each of the common haplotypes and the pooled rare APM1 haplotypes also did not exhibit an allele-sharing proportion that was higher than the null value (data not shown). 

Phrase: "Each of the common haplotypes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0018591:Haplotypes [Organism Attribute]
   760   C0205214:Common [Quantitative Concept]
   760   C1457900:Each [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "the pooled rare APM1 haplotypes also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0018591:Haplotypes [Organism Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "an allele-sharing proportion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709707:Proportion [Quantitative Concept]
   755 E C0205351:Proportional [Qualitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "higher than the null value"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.112: Because the number of ASPs in these analyses was relatively small, we confirmed these results by a simulation-based approach (29,37) (data not shown). 

Phrase: "Because"

Phrase: "the number of ASPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in these analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "relatively small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700321:Small [Quantitative Concept]

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "these results by a simulation-based approach"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "(29,"

Phrase: "37"

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: Thus, the data argued against the hypothesis that genetic variation in the APM1 gene is associated with the evidence for linkage. 

Phrase: "Thus,"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "argued against the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512571:Hypothesis [Idea or Concept]

Phrase: "that genetic variation in the APM1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0042333:Genetic Variation [Natural Phenomenon or Process]
   748   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "associated with the evidence"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0332120:Evidence [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]
Processing 00000000.tx.114: View this table: [in this window] [in a new window]  TABLE 4 Pairwise LD values for SNPs spanning the APM1 gene  View this table: [in this window] [in a new window]  TABLE 5 AEL analysis: APM1 SNPs  Because serum adiponectin levels are significantly reduced in individuals with type 2 diabetes (1921), we postulated that the type 2 diabetes locus at 3q27 may modulate adiponectin levels in the affected members of the families who produced the type 2 diabetes linkage result. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 4 Pairwise LD values for SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0042295:Values [Qualitative Concept]
   706 E C1522609:Value [Quantitative Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 5 AEL analysis"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0796345:linkage analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0004083:Association [Mental Process]
   742   C0023745:linkage [Molecular Function]
   742   C0039224:Table [Manufactured Object]
   742   C0332120:Evidence [Functional Concept]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "APM1 SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "Because"

Phrase: "serum adiponectin levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "significantly"

Phrase: "reduced in individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0392756:Reduced [Qualitative Concept]
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(1921"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "postulated"

Phrase: "that"

Phrase: "the type 2 diabetes locus at 3q27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1708726:Locus [Gene or Genome]

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "adiponectin levels in the affected members of the families"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "who"

Phrase: "produced"

Phrase: "the type 2 diabetes linkage result."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1274040:Result [Functional Concept]
   804   C1546471:Result [Idea or Concept]
   804   C2825142:Result [Finding]
   717   C0011860:Type 2 Diabetes [Disease or Syndrome]
Processing 00000000.tx.115: Serum adiponectin levels were measured in these families, and linkage analysis was carried out with adiponectin levels as a quantitative trait using the EM Haseman-Elston regression method, as implemented in Genehunter. 

Phrase: "Serum adiponectin levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured in these families,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0015576:Families [Family Group]
   770   C0444706:Measured [Qualitative Concept]
   770   C1704727:Family [Conceptual Entity]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "linkage analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0796345:linkage analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0023745:linkage [Molecular Function]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with adiponectin levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0439787:Out [Spatial Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C0849355:Out [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "as a quantitative trait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599883:Trait [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the EM Haseman-Elston regression method,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0034980:Regression Method [Intellectual Product]
   799   C0025663:Method [Intellectual Product]
   799   C0449851:Method [Functional Concept]
   799   C0871511:METHOD [Intellectual Product]

Phrase: "as"

Phrase: "implemented in Genehunter."
Processing 00000000.tx.116: The other quantitative trait linkage analysis methods packaged in Genehunter (the maximum likelihood QTL variance and the nonparametric QTL methods) (34) gave very similar results (data not shown). 

Phrase: "The"

Phrase: "other quantitative trait linkage analysis methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   823   C2707190:Analysis method [Laboratory Procedure]
   804   C0025663:Methods [Intellectual Product]
   804   C0025664:methods [Intellectual Product]
   804   C0449851:Methods [Functional Concept]
   771 E C0871511:METHOD [Intellectual Product]

Phrase: "packaged in Genehunter"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0030176:packaged [Human-caused Phenomenon or Process]
   756 E C0013194:Package [Medical Device]
   756 E C2700580:Package [Manufactured Object]

Phrase: "("

Phrase: "the maximum likelihood QTL variance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1711260:Variance [Qualitative Concept]
   812   C2348152:Variance [Quantitative Concept]
   741 E C0205419:Variant [Qualitative Concept]

Phrase: "and"

Phrase: "the nonparametric QTL methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "(34"

Phrase: ")"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "very similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.117: Figure 1 shows that we identified evidence suggestive of a linkage peak for serum adiponectin levels, with a LOD score of 2.1, that closely matched the position of the type 2 diabetes linkage peak. 

Phrase: "Figure 1"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggestive of a linkage peak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332299:Suggestive of [Functional Concept]
           suggestive

Phrase: "for serum adiponectin levels,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "with a LOD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0332287:With [Qualitative Concept]
   804   C1705690:With [Intellectual Product]
   804   C2986775:Logarithm [Occupational Activity]

Phrase: "score of 2.1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449820:Score [Quantitative Concept]

Phrase: "that closely"

Phrase: "matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:matched [Research Activity]
  1000   C1708943:Matched [Qualitative Concept]

Phrase: "the position of the type 2 diabetes linkage peak."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0733755:Position [Spatial Concept]
Processing 00000000.tx.118: This result was consistent with the idea that the type 2 diabetes susceptibility locus at 3q27 influences both a genetic predisposition to type 2 diabetes and serum adiponectin levels. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "was"

Phrase: "consistent with the idea"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "the type 2 diabetes susceptibility locus at 3q27 influences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1708726:Locus [Gene or Genome]

Phrase: "both a genetic predisposition to type 2 diabetes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0314657:Genetic Predisposition [Organism Attribute]
   744   C0012655:Predisposition [Clinical Attribute]
   744   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   744   C0220898:Predisposition [Organism Attribute]
   744   C0314603:Genetic [Functional Concept]
   739   C0260581:birth type [Health Care Activity]

Phrase: "and"

Phrase: "serum adiponectin levels."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.119: View larger version (23K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.120: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.121: Linkages of type 2 diabetes and serum adiponectin levels to chromosome 3q27 in French early-onset diabetic families. 

Phrase: "Linkages of type 2 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0023745:linkage [Molecular Function]

Phrase: "and"

Phrase: "serum adiponectin levels to chromosome 3q27"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0229671:Serum [Body Substance]
   753   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in French early-onset diabetic families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.122: The approximate position of the APM1 gene relative to the two linkage peaks is shown.   

Phrase: "The approximate position of the APM1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0887940:Gene Position [Molecular Function]
   748   C0733755:Position [Spatial Concept]

Phrase: "relative to the two linkage peaks"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.123: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The aim of the present study was to carry out a detailed reexamination of the genetics of the APM1 locus and its contribution to the genetic basis of susceptibility to type 2 diabetes in the French Caucasian population. 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The aim of the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1947946:Aim [Idea or Concept]
   753   C2948600:Aim [Pharmacologic Substance]
   753   C3540471:AIM [Gene or Genome]
   753   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "a detailed reexamination of the genetics of the APM1 locus"

Phrase: "and"

Phrase: "its contribution to the genetic basis of susceptibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contribution [Activity]

Phrase: "to type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in the French Caucasian population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.124: The G allele of SNP 11426 exhibited modest association with type 2 diabetes, in agreement with a recent study in the Swedish population (27), providing corroborative evidence that SNPs in the promoter region of the APM1 gene contribute to the genetic risk of type 2 diabetes. 

Phrase: "The G allele of SNP 11426 exhibited modest association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Allele [Gene or Genome]

Phrase: "with type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "in the Swedish population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "corroborative evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that SNPs in the promoter region of the APM1 gene"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   751   C0678951:gene polymorphisms [Genetic Function]
   736   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0032529:polymorphisms [Genetic Function]
   736   C0037179:Single [Population Group]
   736   C0087136:single [Finding]
   736   C0205171:Single [Quantitative Concept]
   703 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "contribute to the genetic risk of type 2 diabetes."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0011860:Type 2 Diabetes [Disease or Syndrome]
   764   C0441730:Type 2 [Classification]
   764   C1517512:Genetic Risk [Quantitative Concept]
   762   C1171304:diabetes risk [Quantitative Concept]
   762   C1320657:Diabetes type [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   742   C0035647:Risk [Qualitative Concept]
   742   C0314603:Genetic [Functional Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1880177:Contribute [Activity]
   734   C0260581:birth type [Health Care Activity]
Processing 00000000.tx.125: In the context of study design, it is important to note that the control subjects were younger than the case patients. 

Phrase: "In the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of study design,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0035171:Study Design [Research Activity]
  1000   C2983265:Study Design [Intellectual Product]
           DESIGN
  1000   C2986888:Study Design [Research Activity]
   861   C0557651:Study [Manufactured Object]
   861   C1707689:Design [Activity]
   861   C2603343:Study [Research Activity]

Phrase: "it"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "younger than the case patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332239:Young [Temporal Concept]
Processing 00000000.tx.126: This will tend to decrease the power to detect associations with type 2 diabetes, since it can be postulated that a small proportion of the control subjects are latent type 2 diabetic patients who will go on to develop type 2 diabetes at a later age. 

Phrase: "This"

Phrase: "will"

Phrase: "tend"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "associations with type 2 diabetes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C3645563:Association type [Intellectual Product]
   760   C0004083:Associations [Mental Process]
   726 E C0439849:Association [Qualitative Concept]
   726 E C0596306:Association [Phenomenon or Process]
   726 E C0699792:association [Social Behavior]

Phrase: "since"

Phrase: "it"

Phrase: "can"

Phrase: "be"

Phrase: "postulated"

Phrase: "that"

Phrase: "a small proportion of the control subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709707:Proportion [Quantitative Concept]

Phrase: "are"

Phrase: "latent type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "will"

Phrase: "go on to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1822658:GO [Gene or Genome]

Phrase: "develop"

Phrase: "type 2 diabetes at a later age."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0011860:Type 2 Diabetes [Disease or Syndrome]
   778   C0441730:Type 2 [Classification]
   774   C1320657:Diabetes type [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.127: We obtained strong evidence that haplotypes that contain the major APM1 SNP alleles are associated with normoglycemia, indicating that these haplotypes have a protective effect against type 2 diabetes. 

Phrase: "We"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "strong evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "that"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the major APM1 SNP alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: "are"

Phrase: "associated with normoglycemia,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718   C0580545:Normoglycaemic [Finding]

Phrase: "indicating"

Phrase: "that"

Phrase: "these haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "have"

Phrase: "a protective effect against type 2 diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.128: The implication of the associations reported in the present study is that these variants affect APM1 gene expression and, ultimately thereby, plasma adiponectin levels. 

Phrase: "The implication of the associations"

Phrase: "reported in the present study"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   781   C1317750:Study report [Intellectual Product]
   781   C1831145:Study report [Clinical Attribute]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C2603343:Study [Research Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "is"

Phrase: "that"

Phrase: "these variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "APM1 gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: ","

Phrase: "ultimately thereby,"

Phrase: "plasma adiponectin levels."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0032105:Plasma [Body Substance]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.129: However, we were unable to detect evidence that SNP 11426 or the "1" haplotypes were associated with adiponectin levels. 

Phrase: "However,"

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that SNP 11426"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0752046:SNP [Nucleotide Sequence]
   861   C1527094:SNP [Conceptual Entity]

Phrase: "or"

Phrase: "the ""1"" haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "associated with adiponectin levels."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1547707:Level [Geographic Area]
   737 E C1706221:Associate [Professional or Occupational Group]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.130: Although this seems to weaken the case for these associations, we note the results of two genome scans for adiponectin levels, in the Northern European (44) and Pima Indian populations (45), both of which indicated that the APM1 gene has only a minor influence on circulating adiponectin levels. 

Phrase: "Although"

Phrase: "this"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "weaken"

Phrase: "the case for these associations,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "we"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the results of two genome scans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "for adiponectin levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the Northern European"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0239310:Northern European [Population Group]
   861   C0239307:European [Population Group]
   861   C1535514:European [Population Group]

Phrase: "(44"

Phrase: ")"

Phrase: "and"

Phrase: "Pima Indian populations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
   734   C1551488:Pima Indian [Population Group]

Phrase: "(45"

Phrase: ")"

Phrase: ","

Phrase: "both of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a minor influence on circulating adiponectin levels."
Processing 00000000.tx.131: Thus, if these variants do not influence circulating adiponectin levels, then an alternative hypothesis is that they have a local autocrine/paracrine effect on adiponectin levels in adipose tissue. 

Phrase: "Thus,"

Phrase: "if"

Phrase: "these variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "circulating adiponectin levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0175630:Circulating [Functional Concept]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "an alternative hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1512571:Hypothesis [Idea or Concept]
   861   C1523987:Alternative [Conceptual Entity]

Phrase: "is"

Phrase: "that"

Phrase: "they"

Phrase: "have"

Phrase: "a local autocrine/paracrine effect on adiponectin levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "in adipose tissue."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.132: Further studies are warranted to directly assess the effect of these variants on APM1 gene expression and the mechanism(s) by which they modulate type 2 diabetes susceptibility. 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "warranted"

Phrase: "to directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effect of these variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on APM1 gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "s) by which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2603362:S' [Clinical Attribute]

Phrase: "they"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "type 2 diabetes susceptibility."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0012655:Susceptibility [Clinical Attribute]
   812   C0220898:Susceptibility [Organism Attribute]
   812   C1264642:Susceptibility [Functional Concept]
   812   C1547045:*Susceptibility [Quantitative Concept]
   756   C0011860:Type 2 Diabetes [Disease or Syndrome]
   741 E C0231204:Susceptible [Functional Concept]
   741 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   708   C1320657:type diabetes [Finding]
Processing 00000000.tx.133: The average posterior probability of haplotype inference across the dataset was moderate; 

Phrase: "The average posterior probability of haplotype inference"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033204:Probability [Quantitative Concept]

Phrase: "across the dataset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150098:Data Set [Intellectual Product]
  1000   C1706233:Dataset [Intellectual Product]

Phrase: "was"

Phrase: "moderate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.134: therefore, we have to interpret the haplotype associations with type 2 diabetes and normoglycemia with caution. 

Phrase: "therefore,"

Phrase: "we"

Phrase: "have"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interpret"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285553:interpret [Functional Concept]

Phrase: "the haplotype associations with type 2 diabetes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C3645563:Association type [Intellectual Product]
   748   C0004083:Associations [Mental Process]
   714 E C0439849:Association [Qualitative Concept]
   714 E C0596306:Association [Phenomenon or Process]
   714 E C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "normoglycemia with caution."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0580545:Normoglycaemic [Finding]
Processing 00000000.tx.135: However, we note that the haplotype distribution in this study is very similar to that reported previously (26) and, moreover, that the major alleles of SNPs 11426 to 3971 all have a higher frequency in control subjects (Table 1), consistent with the "1" haplotype association with normoglycemia. 

Phrase: "However,"

Phrase: "we"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the haplotype distribution in this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "is"

Phrase: "very similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "moreover,"

Phrase: "that"

Phrase: "the major alleles of SNPs 11426"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002085:Alleles [Gene or Genome]

Phrase: "to 3971"

Phrase: "all"

Phrase: "have"

Phrase: "a higher frequency in control subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   773   C0205212:High frequency [Temporal Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "consistent with the ""1"" haplotype association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "with normoglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0580545:Normoglycaemic [Finding]
Processing 00000000.tx.136: In general, the case-control data presented here tend to support the hypothesis that genetic variation in the APM1 gene modulates the risk of type 2 diabetes in Northern Europeans. 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "the case-control data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0872128:case control [Health Care Activity]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "tend"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that genetic variation in the APM1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0042333:Genetic Variation [Natural Phenomenon or Process]
   748   C0205419:Variation [Qualitative Concept]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the risk of type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171304:diabetes risk [Quantitative Concept]
   753   C0035647:Risk [Qualitative Concept]

Phrase: "in Northern Europeans."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0239310:Northern European [Population Group]
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]
Processing 00000000.tx.137: However, an independent large-scale case-control study that contains thousands of subjects is urgently required for definitive confirmation of the role of APM1 variants in the genetic basis of type 2 diabetes susceptibility. 

Phrase: "However,"

Phrase: "an independent large-scale case-control study"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   895   C0681367:independent study [Educational Activity]
   861   C0007328:Case-Control Study [Research Activity]
   839   C0085973:Case Study [Intellectual Product]
   827   C0872128:case control [Health Care Activity]
   799   C0243148:control [Qualitative Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0868928:Case [Functional Concept]
   799   C1550141:Control [Substance]
   799   C1706255:CASE [Medical Device]
   799   C1706256:Case [Conceptual Entity]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C2603343:Study [Research Activity]
   799   C3274648:Control [Qualitative Concept]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "thousands of subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883310:Thousand [Quantitative Concept]

Phrase: "is"

Phrase: "urgently"

Phrase: "required for definitive confirmation of the role of APM1 variants"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   739   C0035820:Role [Social Behavior]
   739   C0205419:variants [Qualitative Concept]
   739   C0443196:Definitive [Temporal Concept]
   739   C0750484:Confirmation [Idea or Concept]
   739   C1514873:Required [Functional Concept]
   739   C1540187:APM1 [Gene or Genome]
   739   C1705810:Role [Conceptual Entity]
   739   C2986675:APM1 [Gene or Genome]

Phrase: "in the genetic basis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]

Phrase: "of type 2 diabetes susceptibility."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0012655:Susceptibility [Clinical Attribute]
   812   C0220898:Susceptibility [Organism Attribute]
   812   C1264642:Susceptibility [Functional Concept]
   812   C1547045:*Susceptibility [Quantitative Concept]
   756   C0011860:Type 2 Diabetes [Disease or Syndrome]
   741 E C0231204:Susceptible [Functional Concept]
   741 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   708   C1320657:type diabetes [Finding]
Processing 00000000.tx.138: We have presented evidence that the APM1 gene is an example of a locus with a higher-than-average recombination rate and, therefore, high haplotype diversity and low LD. 

Phrase: "We"

Phrase: "have"

Phrase: "presented evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "an example of a locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707959:Example [Conceptual Entity]

Phrase: "with a higher-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "than-average recombination rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "therefore,"

Phrase: "high haplotype diversity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1880371:Diversity [Qualitative Concept]

Phrase: "and"

Phrase: "low LD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]
Processing 00000000.tx.139: A recent survey of haplotype diversity across 100 candidate genes reported that an average of 4.5 common haplotypes represented 75% of chromosomes in individuals of European descent (46). 

Phrase: "A recent survey of haplotype diversity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0038951:Survey [Intellectual Product]

Phrase: "across 100 candidate genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1332838:Candidate Genes [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "an average of 4.5 common haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1510992:Average [Quantitative Concept]
   748   C2825518:AVERAGE [Quantitative Concept]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "75% of chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0008633:Chromosomes [Cell Component]

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "of European descent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680043:descent [Family Group]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.140: This compares with six haplotypes representing 68% of chromosomes for the APM1 gene, consistent with the idea that the APM1 gene has a higher-than-average haplotype diversity. 

Phrase: "This"

Phrase: "compares with six haplotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018591:Haplotypes [Organism Attribute]
   770   C0205452:Six [Quantitative Concept]
   770   C1707455:Compare [Activity]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "68% of chromosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008633:Chromosomes [Cell Component]
   790   C0450387:68 [Intellectual Product]

Phrase: "for the APM1 gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "consistent with the idea"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "the APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "a higher-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "than-average haplotype diversity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1880371:Diversity [Qualitative Concept]
Processing 00000000.tx.141: The APM1 gene is a strong type 2 diabetes candidate gene in a region of linkage to type 2 diabetes, and it was important to document the results of testing APM1 SNPs for AEL (45). 

Phrase: "The APM1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "a strong type 2 diabetes candidate gene in a region of linkage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1332838:Candidate Gene [Gene or Genome]
   751   C0079429:A Gene [Gene or Genome]
   751   C0314611:Gene type [Genetic Function]
   736   C0017337:Gene [Gene or Genome]

Phrase: "to type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "it"

Phrase: "was"

Phrase: "important to"

Phrase: "document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "the results of testing APM1 SNPs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   750   C0456984:test results [Finding]
   734 E C0587081:Test Result [Finding]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "for AEL"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0004083:Association [Mental Process]
   795   C0023745:linkage [Molecular Function]
   795   C0332120:Evidence [Functional Concept]
   795   C0439849:Association [Qualitative Concept]
   795   C0521125:For [Qualitative Concept]
   795   C0596306:Association [Phenomenon or Process]
   795   C0699792:association [Social Behavior]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.142: We have demonstrated that none of the APM1 SNPs exhibited a level of allele sharing that was higher than that expected under the null hypothesis of no AEL. 

Phrase: "We"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "none of the APM1 SNPs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0456148:None [Quantitative Concept]
   748   C0549184:None [Quantitative Concept]
   748   C1540187:APM1 [Gene or Genome]
   748   C2986675:APM1 [Gene or Genome]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a level of allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "sharing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Sharing [Social Behavior]

Phrase: "that"

Phrase: "was"

Phrase: "higher than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "expected under the null hypothesis of no AEL."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   749   C0332120:Evidence of [Functional Concept]
           Evidence
   735   C0004083:Association [Mental Process]
   735   C0023745:linkage [Molecular Function]
   735   C0439849:Association [Qualitative Concept]
   735   C0456148:Null [Quantitative Concept]
   735   C0596306:Association [Phenomenon or Process]
   735   C0699792:association [Social Behavior]
   735   C1512571:Hypothesis [Idea or Concept]
   735   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.143: Thus, the data argue against the hypothesis that APM1 SNPs are strongly associated with the evidence for linkage at 3q27 and indicate that another, as-yet-unidentified, gene or genes are responsible for the linkage at 3q27. 

Phrase: "Thus,"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "argue against the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512571:Hypothesis [Idea or Concept]

Phrase: "that APM1 SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are"

Phrase: "strongly"

Phrase: "associated with the evidence"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0332120:Evidence [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "at 3q27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521326:3q27 [Cell Component]

Phrase: "and"

Phrase: "indicate"

Phrase: "that"

Phrase: "another,"

Phrase: "as-yet-unidentified, gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1442846:AS gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "or"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "responsible for the linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "at 3q27."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521326:3q27 [Cell Component]
Processing 00000000.tx.144: In the affected members of the early-onset families who produced the type 2 diabetes linkage result at 3q27, we identified evidence suggestive of a linkage peak for serum adiponectin levels that closely matched the position of the type 2 diabetes linkage peak. 

Phrase: "In the affected members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680022:members [Population Group]
   827 E C2698041:Member [Professional or Occupational Group]

Phrase: "of the early-onset families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
   734   C1833334:Early-onset [Finding]

Phrase: "who"

Phrase: "produced"

Phrase: "the type 2 diabetes linkage result at 3q27,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggestive of a linkage peak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332299:Suggestive of [Functional Concept]
           suggestive

Phrase: "for serum adiponectin levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "that closely"

Phrase: "matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:matched [Research Activity]
  1000   C1708943:Matched [Qualitative Concept]

Phrase: "the position of the type 2 diabetes linkage peak."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0733755:Position [Spatial Concept]
Processing 00000000.tx.145: This result suggested the possibility that the type 2 diabetes susceptibility locus at 3q27 influences serum adiponectin levels and is consistent with the observation that serum adiponectin levels are significantly reduced in individuals with type 2 diabetes, independent of the level of adiposity (1921). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the type 2 diabetes susceptibility locus at 3q27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1708726:Locus [Gene or Genome]

Phrase: "influences"

Phrase: "serum adiponectin levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "consistent with the observation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that serum adiponectin levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "significantly"

Phrase: "reduced in individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0392756:Reduced [Qualitative Concept]
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "with type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "independent of the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of adiposity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Adiposity [Disease or Syndrome]
  1000   C1563743:adiposity [Organism Attribute]

Phrase: "(1921"

Phrase: ")."
Processing 00000000.tx.146: The adiponectin linkage result was obtained despite the fact that most of the type 2 diabetic subjects in the genome scan families are receiving insulin-sensitizing drugs (24) that would be expected to have an effect on adiponectin levels, through the close correlation between insulin sensitivity and adiponectin levels (20,21). 

Phrase: "The adiponectin linkage result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "was"

Phrase: "obtained despite the fact"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "that most of the type 2 diabetic subjects"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0441730:Type 2 [Classification]
   744   C0241863:DIABETIC [Finding]
   744   C0332307:Type [Qualitative Concept]
   744   C1547052:*Type [Quantitative Concept]
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]

Phrase: "in the genome scan families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
   734   C1517519:Genome Scan [Molecular Biology Research Technique]

Phrase: "are"

Phrase: "receiving insulin-sensitizing drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   812   C0013227:Drugs [Pharmacologic Substance]
   779 E C1254351:Drug [Pharmacologic Substance]
   741 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   741 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   712 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "(24"

Phrase: ")"

Phrase: "that"

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "an effect on adiponectin levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "through the close correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707520:Correlation [Qualitative Concept]

Phrase: "between insulin sensitivity"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "adiponectin levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.147: We can only speculate that if adiponectin levels had been measured before the onset of pharmacological intervention, then the linkage evidence may have been stronger. 

Phrase: "We"

Phrase: "can"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "speculate"

Phrase: "that"

Phrase: "if"

Phrase: "adiponectin levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "had"

Phrase: "been"

Phrase: "measured before the onset of pharmacological intervention,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   748   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   748   C0205464:pharmacological [Functional Concept]
   748   C0332162:Onset [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0886296:intervention [Health Care Activity]
   748   C1273869:Intervention [Health Care Activity]
   748   C1948041:Intervention [Therapeutic or Preventive Procedure]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the linkage evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "may"

Phrase: "have"

Phrase: "been"

Phrase: "stronger."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   966   C0442821:Strong [Qualitative Concept]
   916 E C0237897:Strength [Quantitative Concept]
   916 E C0808080:Strength [Idea or Concept]
   916 E C1705922:Strength [Qualitative Concept]
Processing 00000000.tx.148: The 3q27 type 2 diabetes susceptibility locus may influence serum adiponectin levels either directly, by affecting APM1 gene expression, or indirectly, by affecting insulin sensitivity. 

Phrase: "The 3q27 type 2 diabetes susceptibility locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1708726:Locus [Gene or Genome]

Phrase: "may"

Phrase: "influence"

Phrase: "serum adiponectin levels either directly,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   804   C0229671:Serum [Body Substance]
   804   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0441889:Levels [Qualitative Concept]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   804   C1947931:Directly [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "by affecting APM1 gene expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0017262:Gene Expression [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "indirectly,"

Phrase: "by affecting insulin sensitivity."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   901   C0920563:Insulin Sensitivity [Pathologic Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036667:Sensitivity [Quantitative Concept]
   827   C0312418:Sensitivity [Mental Process]
   827   C0427965:Sensitivity [Finding]
   827   C1511883:Sensitivity [Quantitative Concept]
   827   C1522640:Sensitivity [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C2346484:SENSITIVITY [Phenomenon or Process]
   827   C2349185:Sensitivity [Qualitative Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332324:Sensitive [Functional Concept]
   755 E C1550474:sensitive [Idea or Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.149: Work is currently in progress to identify the type 2 diabetes susceptibility gene(s) at 3q27 that explains the linkage and characterize the mechanism(s) by which it modulates serum adiponectin levels. 

Phrase: "Work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "currently in progress to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0521116:Currently [Temporal Concept]
   812   C1272688:progress [Functional Concept]
   812   C1280477:Progress [Functional Concept]

Phrase: "identify"

Phrase: "the type 2 diabetes susceptibility gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0919453:Susceptibility Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   717   C0011860:Type 2 Diabetes [Disease or Syndrome]

Phrase: "("

Phrase: "s) at 3q27"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1521326:3q27 [Cell Component]
   790   C2603362:S' [Clinical Attribute]

Phrase: "that"

Phrase: "explains"

Phrase: "the linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "and"

Phrase: "characterize"

Phrase: "the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "s) by which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2603362:S' [Clinical Attribute]

Phrase: "it"

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "serum adiponectin levels."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.150: In conclusion, type 2 diabetes is a complex trait that depends on the interaction of genetic and environmental factors. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "a complex trait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599883:Trait [Organism Attribute]

Phrase: "that"

Phrase: "depends on the interaction of genetic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0314603:Genetic [Functional Concept]
   753   C0725813:depend [Medical Device]
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "environmental factors."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.151: The "obesogenic" environment that exists in most developed countries acts to increase adipose mass, which has the effect of decreasing adiponectin levels and insulin sensitivity. 

Phrase: "The ""obesogenic"" environment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]

Phrase: "that"

Phrase: "exists in most developed countries"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0282613:Developed Countries [Qualitative Concept]
   760   C0454664:Countries [Geographic Area]
   760   C2987476:Exist [Conceptual Entity]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "adipose mass,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "which"

Phrase: "has"

Phrase: "the effect of decreasing adiponectin levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "insulin sensitivity."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.152: The results presented here suggest the testable hypothesis that APM1 variants interact with the environment to influence type 2 diabetes susceptibility via an effect not on circulating adiponectin levels but rather on the adiponectin level within adipose tissue. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the testable hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "that APM1 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "interact with the environment to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014406:Environment [Spatial Concept]

Phrase: "influence"

Phrase: "type 2 diabetes susceptibility via an effect"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "not on circulating adiponectin levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0175630:Circulating [Functional Concept]
   760   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1518422:Not [Functional Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "rather on the adiponectin level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "within adipose tissue."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.153: Thus, the G allele of SNP 11426 predisposes to type 2 diabetes because it exacerbates the obesogenic effect of the environment by promoting low adiponectin levels and a low insulin sensitivity in adipose tissue, whereas the "1" haplotype is protective against type 2 diabetes because it counters the environment by favoring high adiponectin levels and a high insulin sensitivity in adipose tissue.  

Phrase: "Thus,"

Phrase: "the G allele of SNP 11426"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "predisposes to type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "because"

Phrase: "it"

Phrase: "exacerbates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "the obesogenic effect of the environment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
   748   C0871974:environmental effect [Natural Phenomenon or Process]

Phrase: "by promoting low adiponectin levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "a low insulin sensitivity in adipose tissue,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0861023:low insulin [Finding]
   778   C0920563:Insulin Sensitivity [Pathologic Function]
   774   C0234235:Tissue sensitivity [Sign or Symptom]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "whereas"

Phrase: "the ""1"" haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "is"

Phrase: "protective against type 2 diabetes"

Phrase: "because"

Phrase: "it"

Phrase: "counters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0677601:Counter [Manufactured Object]
  1000   C1705206:Counter [Medical Device]

Phrase: "the environment by favoring high adiponectin levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0014406:Environment [Spatial Concept]

Phrase: "and"

Phrase: "a high insulin sensitivity in adipose tissue."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0020459:high insulin [Disease or Syndrome]
   778   C0920563:Insulin Sensitivity [Pathologic Function]
   774   C0234235:Tissue sensitivity [Sign or Symptom]
   774   C1441604:High sensitivity [Laboratory Procedure]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.154: ACKNOWLEDGMENTS  This work is supported by a Wellcome Trust University Award to F.G. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "supported by a Wellcome Trust University Award"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0004446:Award [Manufactured Object]
   748   C0041740:University [Manufactured Object,Organization]
   748   C0237935:Trust [Individual Behavior]
   748   C1521721:Supported [Conceptual Entity]
   748   C3245466:trust [Idea or Concept]
   714 E C0183683:Support [Medical Device]

Phrase: "to F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.155: (GR065414MF) and by grants from Diabetes U.K. 

Phrase: "(GR065414MF"

Phrase: ")"

Phrase: "and by grants"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1515981:And [Idea or Concept]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from Diabetes U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.156: (BDA:RD01/0002308), the Association Franaise des Diabtologues de Langue Franaise (ALFEDIAM), the EU-funded GIFT Grant, the Direction de la Recherche Clinique/Assistance Publique-Hopitaux de Paris, and the program Hospitalier de Recherche Clinique (AOM 96088). 

Phrase: "(BDA:RD01/0002308"

Phrase: ")"

Phrase: ","

Phrase: "the Association Franaise des Diabtologues de Langue Franaise"

Phrase: "(ALFEDIAM"

Phrase: ")"

Phrase: ","

Phrase: "the EU-funded GIFT Grant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0018173:Grant [Quantitative Concept]
   812   C1548284:Grant [Idea or Concept]

Phrase: "the Direction de la Recherche Clinique/Assistance Publique-Hopitaux de Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0030561:Paris [Geographic Area]
   790   C0331677:Paris [Plant]
   790   C1824032:PARIS [Gene or Genome]
   756 E C1824369:PARI [Gene or Genome]

Phrase: "and"

Phrase: "the program Hospitalier de Recherche Clinique"

Phrase: "(AOM 96088"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004519:AOM [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ")."
Processing 00000000.tx.157: We thank Andrew Walley, Christina Dina, and two anonymous reviewers for critically appraising draft versions of the manuscript. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Andrew Walley,"

Phrase: "Christina Dina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1086404:Dina [Eukaryote]

Phrase: "and"

Phrase: "two anonymous reviewers for critically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709941:Reviewer [Qualitative Concept]
   726   C1882950:Reviewer [Population Group]

Phrase: "appraising"

Phrase: "draft versions of the manuscript."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]
Processing 00000000.tx.158: Address correspondence and reprint requests to Fernando Gibson, Genomic Medicine, Imperial College, Hammersmith Campus, Du Cane Road, London W12 0NN, U.K. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Fernando Gibson,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]

Phrase: "Genomic Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "Imperial College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557806:College [Manufactured Object]

Phrase: "Hammersmith Campus,"

Phrase: "Du Cane Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442650:Road [Manufactured Object]

Phrase: "London W12 0NN,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.159: E-mail: fernando.gibson{at}imperial.ac.uk Received for publication April 22, 2004 and accepted in revised form July 28, 2004 AEL, association with the evidence for linkage; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "fernando.gibson{at}imperial.ac.uk"

Phrase: "Received for publication April 22,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2004"

Phrase: "and"

Phrase: "accepted in revised form July 28,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2004 AEL,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0004083:Association [Mental Process]
   748   C0023745:linkage [Molecular Function]
   748   C0332120:Evidence [Functional Concept]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "association with the evidence for linkage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: ";"
Processing 00000000.tx.160: ASP, affected sibling pair; 

Phrase: "ASP,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0037047:Sibling [Family Group]
   827   C0392760:Affected [Functional Concept]
   827   C1314939:Affected [Functional Concept]
   827   C1611273:Sibling [Intellectual Product]
   827   C1709450:Pair [Qualitative Concept]
   793 E C0001721:Affect [Mental Process]

Phrase: "affected sibling pair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709450:Pair [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.161: EM, expectation maximization; 

Phrase: "EM,"

Phrase: "expectation maximization"

Phrase: ";"
Processing 00000000.tx.162: HTR, Haplotype Trend Regression; 

Phrase: "HTR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]

Phrase: "Haplotype Trend Regression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]

Phrase: ";"
Processing 00000000.tx.163: ibd, identical by descent; 

Phrase: "ibd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205280:Identical [Qualitative Concept]

Phrase: "identical by descent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.164: LD, linkage disequilibrium; 

Phrase: "LD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.165: LOD, logarithm of odds; 

Phrase: "LOD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986775:Logarithm [Occupational Activity]

Phrase: "logarithm of odds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986775:Logarithm [Occupational Activity]

Phrase: ";"
Processing 00000000.tx.166: SNP, single nucleotide polymorphism  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Despres JP: The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients risk. 

Phrase: "SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "single nucleotide polymorphism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Despres JP"

Phrase: ":"

Phrase: "The insulin resistance-dyslipidemic syndrome of visceral obesity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0021655:Insulin resistance syndrome [Pathologic Function]
   793   C0524620:Insulin resistance syndrome [Disease or Syndrome]
   767   C1857276:THE SYNDROME [Disease or Syndrome]
   744   C0039082:Syndrome [Disease or Syndrome]

Phrase: ":"

Phrase: "effect on patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "risk."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.167: Obes Res6 (Suppl. 1) :8S 17S,1998[Medline] Astrup A, Finer N: Redefining type 2 diabetes: diabesity or obesity dependent diabetes mellitus? 

Phrase: "Obes Res6"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "8S 17S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552131:17s [Body Part, Organ, or Organ Component]

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Astrup A,"

Phrase: "Finer N"

Phrase: ":"

Phrase: "Redefining type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0011860:Type 2 Diabetes [Disease or Syndrome]
   875   C1320657:type diabetes [Finding]
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "diabesity"

Phrase: "or"

Phrase: "obesity dependent diabetes mellitus?"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C2945676:obesity diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.168: Obes Rev1 :57 59,2000[Medline] Greenberg AS, McDaniel ML: Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. 

Phrase: "Obes Rev1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826797:REV1 [Gene or Genome]

Phrase: ":"

Phrase: "57 59,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Greenberg AS,"

Phrase: "McDaniel ML"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ":"

Phrase: "Identifying"

Phrase: "the links between obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "beta-cell function"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   901   C0007613:Cell Function [Cell Function]
   901   C0030281:Beta cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   827   C2004068:Beta [Qualitative Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: ":"

Phrase: "potential role of adipocyte-derived cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.169: Eur J Clin Invest32 (Suppl. 3) :24 34,2002[Medline] Arner P: The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. 

Phrase: "Eur J Clin Invest32"

Phrase: "(Suppl. 3"

Phrase: ")"

Phrase: ":"

Phrase: "24 34,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Arner P"

Phrase: ":"

Phrase: "The adipocyte in insulin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0206131:Adipocyte [Cell]

Phrase: ":"

Phrase: "key molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "the impact of the thiazolidinediones."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.170: Trends Endocrinol Metab14 :137 145,2003[Medline] Ahima RS, Flier JS: Adipose tissue as an endocrine organ. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Endocrinol Metab14"

Phrase: ":"

Phrase: "137 145,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ahima RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Flier JS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "Adipose tissue as an endocrine organ."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001527:Adipose tissue [Tissue]
   783   C0229524:Endocrine tissue [Tissue]
   753   C0040300:Tissue [Tissue]
   753   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.171: Trends Endocrinol Metab11 :327 332,2000[Medline] Trayhurn P, Beattie JH: Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Endocrinol Metab11"

Phrase: ":"

Phrase: "327 332,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Trayhurn P,"

Phrase: "Beattie JH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: ":"

Phrase: "Physiological role of adipose tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: ":"

Phrase: "white adipose tissue as an endocrine"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1704223:White Adipose Tissue [Tissue]
   790   C0001527:Adipose tissue [Tissue]
   783   C0229524:Endocrine tissue [Tissue]
   753   C0007457:White [Population Group]
   753   C0040300:Tissue [Tissue]
   753   C0043157:White [Population Group]
   753   C0220938:White [Qualitative Concept]
   753   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "secretory organ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178784:Organ [Body Part, Organ, or Organ Component]
Processing 00000000.tx.172: Proc Nutr Soc60 :329 339,2001[Medline] Holst D, Grimaldi PA: New factors in the regulation of adipose differentiation and metabolism. 

Phrase: "Proc Nutr Soc60"

Phrase: ":"

Phrase: "329 339,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Holst D,"

Phrase: "Grimaldi PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: ":"

Phrase: "New factors in the regulation of adipose differentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.173: Curr Opin Lipidol13 :241 245,2002[Medline] Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. 

Phrase: "Curr Opin Lipidol13"

Phrase: ":"

Phrase: "241 245,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimomura I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hammer RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Ikemoto S,"

Phrase: "Brown MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Goldstein JL"

Phrase: ":"

Phrase: "Leptin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1416825:LEPTIN [Gene or Genome]

Phrase: "reverses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes mellitus in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   770   C0011847:Diabetes [Disease or Syndrome]

Phrase: "with congenital lipodystrophy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221032:Congenital lipodystrophy [Congenital Abnormality,Disease or Syndrome]
   861   C0023787:Lipodystrophy [Disease or Syndrome]
Processing 00000000.tx.174: Nature401 :73 76,1999[Medline] Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI: Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. 

Phrase: "Nature401"

Phrase: ":"

Phrase: "73 76,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Petersen KF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427198:KF [Gene or Genome]

Phrase: "Oral EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Dufour S,"

Phrase: "Befroy D,"

Phrase: "Ariyan C,"

Phrase: "Yu C,"

Phrase: "Cline GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "DePaoli"

Phrase: "AM"

Phrase: ","

Phrase: "Taylor SI,"

Phrase: "Gorden P,"

Phrase: "Shulman GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Leptin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1416825:LEPTIN [Gene or Genome]

Phrase: "reverses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "hepatic steatosis in patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0015695:hepatic steatosis [Disease or Syndrome]
   833   C2711227:Hepatic steatosis [Disease or Syndrome]
   770   C0152254:Steatosis [Pathologic Function]
   770   C0205054:Hepatic [Body Location or Region]

Phrase: "with severe lipodystrophy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023787:Lipodystrophy [Disease or Syndrome]
Processing 00000000.tx.175: J Clin Invest109 :1345 1350,2002[Abstract/Free FullText] Sethi JK, Hotamisligil GS: The role of TNF alpha in adipocyte metabolism. 

Phrase: "J Clin Invest109"

Phrase: ":"

Phrase: "1345 1350,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sethi JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Hotamisligil GS"

Phrase: ":"

Phrase: "The role of TNF alpha"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in adipocyte metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.176: Semin Cell Dev Biol10 :19 29,1999[Medline] Lofgren P, van Harmelen V, Reynisdottir S, Naslund E, Ryden M, Rossner S, Arner P: Secretion of tumor necrosis factor- shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. 

Phrase: "Semin Cell Dev Biol10"

Phrase: ":"

Phrase: "19 29,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lofgren P,"

Phrase: "van Harmelen V,"

Phrase: "Reynisdottir S,"

Phrase: "Naslund E,"

Phrase: "Ryden M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rossner S,"

Phrase: "Arner P"

Phrase: ":"

Phrase: "Secretion of tumor necrosis factor-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a strong relationship to insulin-stimulated glucose transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]

Phrase: "in human adipose tissue."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0440744:Human tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.177: Diabetes49 :688 692,2000[Abstract] Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. 

Phrase: "Diabetes49"

Phrase: ":"

Phrase: "688 692,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Steppan CM,"

Phrase: "Bailey ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Bhat S,"

Phrase: "Brown EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Banerjee RR,"

Phrase: "Wright CM,"

Phrase: "Patel HR,"

Phrase: "Ahima RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Lazar MA"

Phrase: ":"

Phrase: "The hormone resistin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1426906:RESISTIN [Gene or Genome]

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "obesity to diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C2945676:diabetes obesity [Finding]
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1963185:Obesity [Finding]
Processing 00000000.tx.178: Nature409 :307 312,2001[Medline] Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA: Regulation of fasted blood glucose by resistin. 

Phrase: "Nature409"

Phrase: ":"

Phrase: "307 312,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Banerjee RR,"

Phrase: "Rangwala SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Shapiro JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Rich AS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0699759:Rich [Qualitative Concept]

Phrase: "Rhoades B,"

Phrase: "Qi Y,"

Phrase: "Wang J,"

Phrase: "Rajala MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Pocai A,"

Phrase: "Scherer PE,"

Phrase: "Steppan CM,"

Phrase: "Ahima RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Obici S,"

Phrase: "Rossetti L,"

Phrase: "Lazar MA"

Phrase: ":"

Phrase: "Regulation of fasted blood glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by resistin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1426906:RESISTIN [Gene or Genome]
Processing 00000000.tx.179: Science303 :1195 1198,2004[Abstract/Free FullText] Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. 

Phrase: "Science303"

Phrase: ":"

Phrase: "1195 1198,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fruebis J,"

Phrase: "Tsao TS,"

Phrase: "Javorschi S,"

Phrase: "Ebbets-Reed D,"

Phrase: "Erickson MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Yen FT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881534:ft. [Functional Concept]

Phrase: "Bihain"

Phrase: "BE"

Phrase: ","

Phrase: "Lodish HF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018488:Hf [Element, Ion, or Isotope]
   861   C1538440:HF [Gene or Genome]
   861   C3273279:HF [Gene or Genome]

Phrase: ":"

Phrase: "Proteolytic cleavage product of 30-kDa adipocyte complement-related protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0597304:Protein Cleavage [Molecular Function]
   739   C0010813:cleavage [Cell Function]
   739   C0596311:Cleavage [Phenomenon or Process]
   739   C1330957:cleavage [Cell Function]
   739   C1514468:product [Entity]
   739   C1704444:Product [Quantitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "fatty acid oxidation in muscle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1158366:fatty acid oxidation [Molecular Function]
   806   C0015684:Fatty acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0030011:Oxidation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "weight loss in mice."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0043096:WEIGHTLOSS [Finding]
   833   C2911645:Weight loss [Finding]
   770   C0005910:weight [Organism Attribute]
   770   C0043100:Weight [Quantitative Concept]
   770   C1305866:weight [Diagnostic Procedure]
   770   C1517945:Loss [Quantitative Concept]
   770   C1705104:Weight [Idea or Concept]
Processing 00000000.tx.180: Proc Natl Acad Sci U S A98 :2005 2010,2001[Abstract/Free FullText] Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. 

Phrase: "Proc Natl Acad Sci U S A98"

Phrase: ":"

Phrase: "2005 2010,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yamauchi T,"

Phrase: "Kamon J,"

Phrase: "Minokoshi Y,"

Phrase: "Ito Y,"

Phrase: "Waki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Uchida S,"

Phrase: "Yamashita S,"

Phrase: "Noda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kita S,"

Phrase: "Ueki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Eto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Akanuma Y,"

Phrase: "Froguel P,"

Phrase: "Foufelle F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ferre P,"

Phrase: "Carling D,"

Phrase: "Kimura S,"

Phrase: "Nagai R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kahn BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Kadowaki T"

Phrase: ":"

Phrase: "Adiponectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "stimulates"

Phrase: "glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "fatty-acid oxidation by activating AMP-activated protein kinase."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1158366:fatty acid oxidation [Molecular Function]
   764   C0015684:Fatty acid [Lipid]
   762   C1159301:protein oxidation [Molecular Function]
   742   C0001128:Acid [Chemical]
   742   C0030011:Oxidation [Molecular Function]
   742   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.181: Nat Med8 :1288 1295,2002[Medline] Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T: Disruption of adiponectin causes insulin resistance and neointimal formation. 

Phrase: "Nat Med8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1426572:MED8 [Gene or Genome]

Phrase: ":"

Phrase: "1288 1295,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kubota N,"

Phrase: "Terauchi Y,"

Phrase: "Yamauchi T,"

Phrase: "Kubota T,"

Phrase: "Moroi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Matsui J,"

Phrase: "Eto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yamashita T,"

Phrase: "Kamon J,"

Phrase: "Satoh H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yano W,"

Phrase: "Froguel P,"

Phrase: "Nagai R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kimura S,"

Phrase: "Kadowaki T,"

Phrase: "Noda T"

Phrase: ":"

Phrase: "Disruption of adiponectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332453:Disruption [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "neointimal formation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   964   C2936381:Neointima Formation [Pathologic Function]
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.182: J Biol Chem277 :25863 25866,2002[Abstract/Free FullText] Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. 

Phrase: "J Biol Chem277"

Phrase: ":"

Phrase: "25863 25866,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Maeda N,"

Phrase: "Shimomura I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kishida K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nishizawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Matsuda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nagaretani H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Furuyama N,"

Phrase: "Kondo H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Takahashi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Arita Y,"

Phrase: "Komuro R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ouchi N,"

Phrase: "Kihara S,"

Phrase: "Tochino Y,"

Phrase: "Okutomi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Horie M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Takeda S,"

Phrase: "Aoyama T,"

Phrase: "Funahashi T,"

Phrase: "Matsuzawa Y"

Phrase: ":"

Phrase: "Diet-induced insulin resistance in mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "adiponectin/ACRP30."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0389071:ACRP30 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1540187:ACRP30 [Gene or Genome]
   861   C2986675:ACRP30 [Gene or Genome]
Processing 00000000.tx.183: Nat Med8 :731 737,2002[Medline] Ma K, Cabrero A, Saha PK, Kojima H, Li L, Chang BH, Paul A, Chan L: Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. 

Phrase: "Nat Med8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1426572:MED8 [Gene or Genome]

Phrase: ":"

Phrase: "731 737,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ma K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cabrero A,"

Phrase: "Saha PK,"

Phrase: "Kojima H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Li L,"

Phrase: "Chang BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Paul A,"

Phrase: "Chan L"

Phrase: ":"

Phrase: "Increased beta-oxidation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0030011:Oxidation [Molecular Function]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "but"

Phrase: "no insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "glucose intolerance in mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0271650:Glucose Intolerance [Disease or Syndrome]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0231199:Intolerance [Organism Function]
   770   C1744706:intolerance [Intellectual Product]
   770   C2355652:Intolerance [Organism Attribute]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "adiponectin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.184: J Biol Chem277 :34658 34661,2002[Abstract/Free FullText] Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. 

Phrase: "J Biol Chem277"

Phrase: ":"

Phrase: "34658 34661,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hotta K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Funahashi T,"

Phrase: "Arita Y,"

Phrase: "Takahashi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Matsuda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Okamoto Y,"

Phrase: "Iwahashi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kuriyama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ouchi N,"

Phrase: "Maeda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nishida M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kihara S,"

Phrase: "Sakai N,"

Phrase: "Nakajima T,"

Phrase: "Hasegawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Muraguchi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ohmoto Y,"

Phrase: "Nakamura T,"

Phrase: "Yamashita S,"

Phrase: "Hanafusa T,"

Phrase: "Matsuzawa Y"

Phrase: ":"

Phrase: "Plasma concentrations of a novel, adipose-specific protein,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0683150:concentrations plasma [Quantitative Concept]
   750   C0427716:Protein concentration [Laboratory Procedure]
   750   C1304757:Protein concentration [Laboratory or Test Result]
   744   C0086045:Concentrations [Mental Process]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "adiponectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in type 2 diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.185: Arterioscler Thromb Vasc Biol20 :1595 1599,2000[Abstract/Free FullText] Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y: Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. 

Phrase: "Arterioscler Thromb Vasc Biol20"

Phrase: ":"

Phrase: "1595 1599,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hotta K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Funahashi T,"

Phrase: "Bodkin NL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027778:NL [Geographic Area]
   861   C0560008:nL [Quantitative Concept]

Phrase: "Ortmeyer HK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "Arita Y,"

Phrase: "Hansen BC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2984916:BC [Quantitative Concept]

Phrase: "Matsuzawa Y"

Phrase: ":"

Phrase: "Circulating concentrations of the adipocyte protein adiponectin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0427716:Protein concentration [Laboratory Procedure]
   757   C1304757:Protein concentration [Laboratory or Test Result]
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "are"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "in parallel with reduced insulin sensitivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]
   753   C2348042:Parallel [Qualitative Concept]
   753   C2826345:PARALLEL [Research Activity]

Phrase: "during the progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "to type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in rhesus monkeys."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024400:rhesus monkeys [Mammal]
           Rhesus
   861   C0026447:Monkeys [Mammal]
Processing 00000000.tx.186: Diabetes50 :1126 1133,2001[Abstract/Free FullText] Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. 

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "1126 1133,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Weyer C,"

Phrase: "Funahashi T,"

Phrase: "Tanaka S,"

Phrase: "Hotta K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Matsuzawa Y,"

Phrase: "Pratley RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Tataranni PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: ":"

Phrase: "Hypoadiponectinemia in obesity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2675519:Hypoadiponectinemia [Disease or Syndrome]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "close association with insulin resistance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "hyperinsulinemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]
Processing 00000000.tx.187: J Clin Endocrinol Metab86 :1930 1935,2001[Abstract/Free FullText] Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 

Phrase: "J Clin Endocrinol Metab86"

Phrase: ":"

Phrase: "1930 1935,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Arita Y,"

Phrase: "Kihara S,"

Phrase: "Ouchi N,"

Phrase: "Takahashi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Maeda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Miyagawa J,"

Phrase: "Hotta K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Shimomura I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Nakamura T,"

Phrase: "Miyaoka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kuriyama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nishida M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamashita S,"

Phrase: "Okubo K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Matsubara K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Muraguchi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ohmoto Y,"

Phrase: "Funahashi T,"

Phrase: "Matsuzawa Y"

Phrase: ":"

Phrase: "Paradoxical decrease of an adipose-specific protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "adiponectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in obesity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]
Processing 00000000.tx.188: Biochem Biophys Res Commun257 :79 83,1999[Medline] Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG, Marks JA, Krakower GR, Jacob HJ, Weber J, Martin L, Blangero J, Comuzzie AG: Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. 

Phrase: "Biochem Biophys Res Commun257"

Phrase: ":"

Phrase: "79 83,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kissebah AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Sonnenberg GE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: "Myklebust J,"

Phrase: "Goldstein M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Broman K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "James RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Marks JA,"

Phrase: "Krakower GR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "Jacob HJ,"

Phrase: "Weber J,"

Phrase: "Martin L,"

Phrase: "Blangero J,"

Phrase: "Comuzzie AG"

Phrase: ":"

Phrase: "Quantitative trait loci on chromosomes 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0597336:Quantitative Trait Loci [Gene or Genome]
   753   C0392762:Quantitative [Quantitative Concept]
   753   C0599883:Trait [Organism Attribute]
   719   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "17 influence phenotypes of the metabolic syndrome."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0031437:Phenotypes [Organism Attribute]
   714 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.189: Proc Natl Acad Sci U S A97 :14478 14483,2000[Abstract/Free FullText] Vionnet N, Hani El H, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froguel P: Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21q24. 

Phrase: "Proc Natl Acad Sci U S A97"

Phrase: ":"

Phrase: "14478 14483,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vionnet N,"

Phrase: "Hani El H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Dupont S,"

Phrase: "Gallina S,"

Phrase: "Francke S,"

Phrase: "Dotte S,"

Phrase: "De Matos F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Durand E,"

Phrase: "Lepretre F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lecoeur C,"

Phrase: "Gallina P,"

Phrase: "Zekiri L,"

Phrase: "Dina C,"

Phrase: "Froguel P"

Phrase: ":"

Phrase: "Genomewide search for type 2 diabetes-susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1552603:search [Intellectual Product]
   744   C1706202:Search [Activity]

Phrase: "in French whites"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0007457:Whites [Population Group]
   861   C0043157:Whites [Population Group]
   827 E C0220938:White [Qualitative Concept]

Phrase: ":"

Phrase: "evidence for a novel susceptibility locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "for early-onset diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1833334:Early-onset [Finding]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: "on chromosome 3q27-qter"

Phrase: "and"

Phrase: "independent replication of a type 2-diabetes locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0598312:Replication [Genetic Function]
   744   C1883725:replication [Qualitative Concept]

Phrase: "on chromosome 1q21q24."
Processing 00000000.tx.190: Am J Hum Genet67 :1470 1480,2000[Medline] Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. 

Phrase: "Am"

Phrase: "J Hum Genet67"

Phrase: ":"

Phrase: "1470 1480,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hara K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Boutin P,"

Phrase: "Mori Y,"

Phrase: "Tobe K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Dina C,"

Phrase: "Yasuda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yamauchi T,"

Phrase: "Otabe S,"

Phrase: "Okada T,"

Phrase: "Eto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kadowaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hagura R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Akanuma Y,"

Phrase: "Yazaki Y,"

Phrase: "Nagai R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Taniyama M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Matsubara K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yoda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nakano Y,"

Phrase: "Tomita M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kimura S,"

Phrase: "Ito C,"

Phrase: "Froguel P,"

Phrase: "Kadowaki T"

Phrase: ":"

Phrase: "Genetic variation in the gene encoding adiponectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0042333:Genetic Variation [Natural Phenomenon or Process]
   748   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "associated with an increased risk of type 2 diabetes"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   790   C0011860:Type 2 Diabetes [Disease or Syndrome]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C0441730:Type 2 [Classification]
   762   C1171304:diabetes risk [Quantitative Concept]
   762   C1320657:Diabetes type [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0035647:Risk [Qualitative Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the Japanese population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.191: Diabetes51 :536 540,2002[Abstract/Free FullText] Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Lepretre F, Dupont S, Hara K, Clement K, Bihain B, Kadowaki T, Froguel P: Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "536 540,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vasseur F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Helbecque N,"

Phrase: "Dina C,"

Phrase: "Lobbens S,"

Phrase: "Delannoy V,"

Phrase: "Gaget S,"

Phrase: "Boutin P,"

Phrase: "Vaxillaire M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lepretre F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Dupont S,"

Phrase: "Hara K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Clement K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bihain B,"

Phrase: "Kadowaki T,"

Phrase: "Froguel P"

Phrase: ":"

Phrase: "Single-nucleotide polymorphism haplotypes in the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0018591:Haplotypes [Organism Attribute]

Phrase: "both proximal promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "exon 3 of the APM1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017337:Gene [Gene or Genome]
   753   C1540187:APM1 [Gene or Genome]
   753   C2986675:APM1 [Gene or Genome]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "adipocyte-secreted adiponectin hormone levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   840   C1287355:hormone levels [Laboratory or Test Result]
   804   C0019932:Hormone [Hormone]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   733 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "contribute to the genetic risk"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   806   C1517512:Genetic Risk [Quantitative Concept]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0035647:Risk [Qualitative Concept]
   760   C0314603:Genetic [Functional Concept]
   760   C1880177:Contribute [Activity]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "for type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in French Caucasians."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007457:Caucasians [Population Group]
   861   C0043157:Caucasians [Population Group]
Processing 00000000.tx.192: Hum Mol Genet11 :2607 2614,2002[Abstract/Free FullText] Gu HF, Abulaiti A, Ostenson CG, Humphreys K, Wahlestedt C, Brookes AJ, Efendic S: Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. 

Phrase: "Hum Mol Genet11"

Phrase: ":"

Phrase: "2607 2614,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gu HF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018488:Hf [Element, Ion, or Isotope]
   861   C1538440:HF [Gene or Genome]
   861   C3273279:HF [Gene or Genome]

Phrase: "Abulaiti A,"

Phrase: "Ostenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Humphreys K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Wahlestedt C,"

Phrase: "Brookes AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Efendic S"

Phrase: ":"

Phrase: "Single nucleotide polymorphisms in the proximal promoter region of the adiponectin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   775   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   738   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0032529:polymorphisms [Genetic Function]
   738   C0037179:Single [Population Group]
   738   C0087136:single [Finding]
   738   C0205171:Single [Quantitative Concept]
   704 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(APM1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1540187:APM1 [Gene or Genome]
  1000   C2986675:APM1 [Gene or Genome]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "are"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Swedish Caucasians."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007457:Caucasians [Population Group]
   861   C0043157:Caucasians [Population Group]
Processing 00000000.tx.193: Diabetes53 (Suppl. 1) :S31 S35,2004[Medline] Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 

Phrase: "Diabetes53"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "S31 S35,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Expert Committee on the Diagnosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2699414:Committee [Group]

Phrase: "and"

Phrase: "Classification of Diabetes Mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classification [Classification]
   770   C0008903:classification [Functional Concept]
   770   C0678229:classification [Occupational Activity]

Phrase: ":"

Phrase: "Report of the Expert Committee"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "on the Diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "Classification of Diabetes Mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classification [Classification]
   770   C0008903:classification [Functional Concept]
   770   C0678229:classification [Occupational Activity]
Processing 00000000.tx.194: Diabetes Care26 (Suppl. 1) :S5 S20,2003[Medline] Boutin P, Dina C, Vasseur F, Dubois SS, Corset L, Seron K, Bekris L, Cabellon J, Neve B, Vasseur-Delannoy V, Chikri M, Charles MA, Clement K, Lernmark A, Froguel P: GAD2 on chromosome 10p12 is a candidate gene for human obesity. 

Phrase: "Diabetes Care26"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "S5 S20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419719:S20 [Gene or Genome]

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Boutin P,"

Phrase: "Dina C,"

Phrase: "Vasseur F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Dubois SS,"

Phrase: "Corset L,"

Phrase: "Seron K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bekris L,"

Phrase: "Cabellon J,"

Phrase: "Neve B,"

Phrase: "Vasseur-Delannoy V,"

Phrase: "Chikri M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Charles MA,"

Phrase: "Clement K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lernmark A,"

Phrase: "Froguel P"

Phrase: ":"

Phrase: "GAD2 on chromosome 10p12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1414926:GAD2 [Gene or Genome]
   770   C2825893:GAD2 [Laboratory Procedure]

Phrase: "is"

Phrase: "a candidate gene for human obesity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1332838:Candidate Gene [Gene or Genome]
   783   C0079429:A Gene [Gene or Genome]
   783   C0314604:Human gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.195: PLoS Biol1 :E68 ,2003[Medline] Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. 

Phrase: "PLoS Biol1"

Phrase: ":"

Phrase: "E68 ,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stephens M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Smith NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Donnelly P"

Phrase: ":"

Phrase: "A new statistical method for haplotype reconstruction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1710191:Statistical Method [Research Activity]
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "from population data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.196: Am J Hum Genet68 :978 989,2001[Medline] Li N, Stephens M: Modeling linkage disequilibrium and identifying recombination hotspots using single-nucleotide polymorphism data. 

Phrase: "Am"

Phrase: "J Hum Genet68"

Phrase: ":"

Phrase: "978 989,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li N,"

Phrase: "Stephens M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Modeling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870071:Modeling [Intellectual Product,Research Activity]
   966 E C3161035:Model [Intellectual Product]

Phrase: "linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "identifying recombination hotspots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2986491:Hotspot [Nucleotide Sequence]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "single-nucleotide polymorphism data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]
   756   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
Processing 00000000.tx.197: Genetics165 :2213 2233,2003[Abstract/Free FullText] Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG: Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. 

Phrase: "Genetics165"

Phrase: ":"

Phrase: "2213 2233,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zaykin DV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0279354:DV [Therapeutic or Preventive Procedure]
   861   C1704645:DV [Conceptual Entity]

Phrase: "Westfall PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Young SS,"

Phrase: "Karnoub MA,"

Phrase: "Wagner MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Ehm MG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ":"

Phrase: "Testing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]

Phrase: "association of statistically inferred haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with discrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699782:Discrete [Qualitative Concept]

Phrase: "and"

Phrase: "continuous traits in samples of unrelated individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0599883:traits [Organism Attribute]
   748   C1427926:TRAITS [Gene or Genome]
Processing 00000000.tx.198: Hum Hered53 :79 91,2002[Medline] Abecasis GR, Cookson WO: GOLDgraphical overview of linkage disequilibrium. 

Phrase: "Hum Hered53"

Phrase: ":"

Phrase: "79 91,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Abecasis GR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "Cookson WO"

Phrase: ":"

Phrase: "GOLDgraphical overview of linkage disequilibrium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0814812:overview [Intellectual Product]
Processing 00000000.tx.199: Bioinformatics16 :182 183,2000[Abstract] Kruglyak L, Lander ES: Complete multipoint sib-pair analysis of qualitative and quantitative traits. 

Phrase: "Bioinformatics16"

Phrase: ":"

Phrase: "182 183,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kruglyak L,"

Phrase: "Lander ES"

Phrase: ":"

Phrase: "Complete multipoint sib-pair analysis of qualitative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   743   C2825412:Paired Analysis [Idea or Concept]

Phrase: "and"

Phrase: "quantitative traits."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599883:traits [Organism Attribute]
   861   C1427926:TRAITS [Gene or Genome]
Processing 00000000.tx.200: Am J Hum Genet57 :439 454,1995[Medline] Risch N: Linkage strategies for genetically complex traits. 

Phrase: "Am"

Phrase: "J Hum Genet57"

Phrase: ":"

Phrase: "439 454,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Risch N"

Phrase: ":"

Phrase: "Linkage strategies for genetically complex traits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679199:strategies [Mental Process]
Processing 00000000.tx.201: III. 

Phrase: "III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]
Processing 00000000.tx.202: The effect of marker polymorphism on analysis of affected relative pairs. 

Phrase: "The effect of marker polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of affected relative pairs."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C0392760:Affected [Functional Concept]
   827   C1314939:Affected [Functional Concept]
   827   C1547039:*Relative [Quantitative Concept]
   827   C1709450:Pair [Qualitative Concept]
   793 E C0001721:Affect [Mental Process]
Processing 00000000.tx.203: Am J Hum Genet46 :242 253,1990[Medline] Haseman JK, Elston RC: The investigation of linkage between a quantitative trait and a marker locus. 

Phrase: "Am"

Phrase: "J Hum Genet46"

Phrase: ":"

Phrase: "242 253,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Haseman JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Elston RC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: ":"

Phrase: "The investigation of linkage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Investigation [Health Care Activity]
   770   C1552578:investigation [Idea or Concept]

Phrase: "between a quantitative trait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599883:Trait [Organism Attribute]

Phrase: "and"

Phrase: "a marker locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.204: Behav Genet2 :3 19,1972[Medline] Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. 

Phrase: "Behav Genet2"

Phrase: ":"

Phrase: "3 19,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "1972"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Horikawa Y,"

Phrase: "Oda N,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Li X,"

Phrase: "Orho-Melander M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Hara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hinokio Y,"

Phrase: "Lindner TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "Mashima H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Schwarz PE,"

Phrase: "del Bosque-Plata L,"

Phrase: "Oda Y,"

Phrase: "Yoshiuchi I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Colilla S,"

Phrase: "Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Wei S,"

Phrase: "Concannon P,"

Phrase: "Iwasaki N,"

Phrase: "Schulze J,"

Phrase: "Baier LJ,"

Phrase: "Bogardus C,"

Phrase: "Groop L,"

Phrase: "Boerwinkle E,"

Phrase: "Hanis CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Bell GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Genetic variation in the gene encoding calpain-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0042333:Genetic Variation [Natural Phenomenon or Process]
   744   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "associated with type 2 diabetes mellitus."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   882   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   882   C2984301:Type II diabetes mellitus [Functional Concept]
   790   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.205: Nat Genet26 :163 175,2000[Medline] Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. 

Phrase: "Nat Genet26"

Phrase: ":"

Phrase: "163 175,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matthews DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Hosker JP,"

Phrase: "Rudenski AS,"

Phrase: "Naylor BA,"

Phrase: "Treacher DF,"

Phrase: "Turner RC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: ":"

Phrase: "Homeostasis model assessment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1829779:Homeostasis model assessment [Laboratory Procedure]
  1000   C1830060:Homeostasis model assessment [Clinical Attribute]
   827   C0019868:Homeostasis [Biologic Function]
   827   C1261322:Assessment [Health Care Activity]
   827   C1516048:Assessment [Activity]
   827   C3161035:Model [Intellectual Product]

Phrase: ":"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "beta-cell function from fasting plasma glucose"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0007613:Cell Function [Cell Function]
   778   C0030281:Beta cell [Cell]
   774   C0032112:Plasma cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0031843:function [Physiologic Function]
   748   C0330390:Beta [Plant]
   748   C0439096:Beta [Intellectual Product]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1705273:Function [Intellectual Product]
   748   C1948049:Cell [Spatial Concept]
   748   C2004068:Beta [Qualitative Concept]

Phrase: "and"

Phrase: "insulin concentrations in man."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.206: Diabetologia28 :412 419,1985[Medline] Weiss KM, Clark AG: Linkage disequilibrium and the mapping of complex human traits. 

Phrase: "Diabetologia28"

Phrase: ":"

Phrase: "412 419,"

Phrase: "1985"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weiss KM,"

Phrase: "Clark AG"

Phrase: ":"

Phrase: "Linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "the mapping of complex human traits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1283195:Mapping [Activity]
Processing 00000000.tx.207: Trends Genet18 :19 24,2002[Medline] Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA: Haplotype tagging for the identification of common disease genes. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet18"

Phrase: ":"

Phrase: "19 24,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnson GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Esposito L,"

Phrase: "Barratt BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Smith"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "AN,"

Phrase: "Heward J,"

Phrase: "Di Genova G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Ueda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Cordell HJ,"

Phrase: "Eaves IA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: "Dudbridge F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Twells RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Payne F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Hughes W,"

Phrase: "Nutland S,"

Phrase: "Stevens H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Carr P,"

Phrase: "Tuomilehto-Wolf E,"

Phrase: "Tuomilehto J,"

Phrase: "Gough SC,"

Phrase: "Clayton DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Todd JA"

Phrase: ":"

Phrase: "Haplotype tagging for the identification of common disease genes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C0037293:Tag [Neoplastic Process]
   708   C0181496:Tag [Manufactured Object]
   708   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.208: Nat Genet29 :233 237,2001[Medline] Groves CJ, Wiltshire S, Smedley D, Owen KR, Frayling TM, Walker M, Hitman GA, Levy JC, ORahilly S, Menzel S, Hattersley AT, McCarthy MI: Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. 

Phrase: "Nat Genet29"

Phrase: ":"

Phrase: "233 237,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Groves CJ,"

Phrase: "Wiltshire S,"

Phrase: "Smedley D,"

Phrase: "Owen KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Walker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hitman GA,"

Phrase: "Levy JC,"

Phrase: "ORahilly S,"

Phrase: "Menzel S,"

Phrase: "Hattersley AT,"

Phrase: "McCarthy MI"

Phrase: ":"

Phrase: "Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "haplotype analysis of the insulin-degrading enzyme (IDE) gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "a strong positional"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0240795:POSITIONAL [Finding]
   789 E C0733755:Position [Spatial Concept]

Phrase: "and"

Phrase: "biological candidate for type 2 diabetes susceptibility."
Processing 00000000.tx.209: Diabetes52 :1300 1305,2003[Abstract/Free FullText] Zhu X, Yan D, Cooper RS, Luke A, Ikeda MA, Chang YP, Weder A, Chakravarti A: Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "1300 1305,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhu X,"

Phrase: "Yan D,"

Phrase: "Cooper RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Luke A,"

Phrase: "Ikeda MA,"

Phrase: "Chang YP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520214:Yp [Nucleotide Sequence]

Phrase: "Weder A,"

Phrase: "Chakravarti A"

Phrase: ":"

Phrase: "Linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "haplotype diversity in the genes of the renin-angiotensin system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880371:Diversity [Qualitative Concept]

Phrase: ":"

Phrase: "findings from the family blood pressure program."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   788   C1271104:Blood pressure finding [Finding]
   757   C0460139:Pressure (finding) [Finding]
   748   C2607943:findings [Functional Concept]
   748   C2926606:Findings [Clinical Attribute]
   748   C3539655:Findings [Intellectual Product]
   716   C0425654:Blood vessel finding [Finding]
   714 E C0037088:Finding [Sign or Symptom]
   714 E C0243095:Finding [Finding]
   714 E C2825141:Finding [Finding]
Processing 00000000.tx.210: Genome Res13 :173 181,2003[Abstract/Free FullText] Pritchard JK, Przeworski M: Linkage disequilibrium in humans: models and data. 

Phrase: "Genome Res13"

Phrase: ":"

Phrase: "173 181,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pritchard JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Przeworski M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Linkage disequilibrium in humans"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: ":"

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]
Processing 00000000.tx.211: Am J Hum Genet69 :1 14,2001[Medline] Comuzzie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob HJ, Black AE, Maas D, Takahashi M, Kihara S, Tanaka S, Matsuzawa Y, Blangero J, Cohen D, Kissebah A: The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. 

Phrase: "Am"

Phrase: "J Hum Genet69"

Phrase: ":"

Phrase: "1 14,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Comuzzie AG,"

Phrase: "Funahashi T,"

Phrase: "Sonnenberg G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Martin LJ,"

Phrase: "Jacob HJ,"

Phrase: "Black AE,"

Phrase: "Maas D,"

Phrase: "Takahashi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kihara S,"

Phrase: "Tanaka S,"

Phrase: "Matsuzawa Y,"

Phrase: "Blangero J,"

Phrase: "Cohen D,"

Phrase: "Kissebah A"

Phrase: ":"

Phrase: "The genetic basis of plasma variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: "in adiponectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a global endophenotype for obesity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2936327:Endophenotype [Qualitative Concept]

Phrase: "and"

Phrase: "the metabolic syndrome."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0524620:Metabolic syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]
Processing 00000000.tx.212: J Clin Endocrinol Metab86 :4321 4325,2001[Abstract/Free FullText] Lindsay RS, Funahashi T, Krakoff J, Matsuzawa Y, Tanaka S, Kobes S, Bennett PH, Tataranni PA, Knowler WC, Hanson RL: Genome-wide linkage analysis of serum adiponectin in the Pima Indian population. 

Phrase: "J Clin Endocrinol Metab86"

Phrase: ":"

Phrase: "4321 4325,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lindsay RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Funahashi T,"

Phrase: "Krakoff J,"

Phrase: "Matsuzawa Y,"

Phrase: "Tanaka S,"

Phrase: "Kobes S,"

Phrase: "Bennett PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Tataranni PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Knowler WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Hanson RL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: ":"

Phrase: "Genome-wide linkage analysis of serum adiponectin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0796345:linkage analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0023745:linkage [Molecular Function]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in the Pima Indian population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
   734   C1551488:Pima Indian [Population Group]
Processing 00000000.tx.213: Diabetes52 :2419 2425,2003[Abstract/Free FullText] Crawford DC, Carlson CS, Rieder MJ, Carrington DP, Yi Q, Smith JD, Eberle MA, Kruglyak L, Nickerson DA: Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "2419 2425,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Crawford DC,"

Phrase: "Carlson CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Rieder MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Carrington DP,"

Phrase: "Yi Q,"

Phrase: "Smith JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Eberle MA,"

Phrase: "Kruglyak L,"

Phrase: "Nickerson DA"

Phrase: ":"

Phrase: "Haplotype diversity across 100 candidate genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880371:Diversity [Qualitative Concept]

Phrase: "for inflammation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "lipid metabolism,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "blood pressure regulation in two populations."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0678863:blood pressure regulation [Organism Function]
   790   C0005823:Blood Pressure [Organism Function]
   790   C1271104:Blood Pressure [Finding]
   790   C1272641:Blood pressure [Finding]
   783   C0032676:Population Pressure [Quantitative Concept]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0033095:Pressure [Phenomenon or Process]
   753   C0229664:Blood [Body Substance]
   753   C0460139:Pressure [Finding]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1306345:Pressure [Functional Concept]
   753   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.214: Am J Hum Genet74 :610 622,2004[Medline]

Phrase: "Am"

Phrase: "J Hum Genet74"

Phrase: ":"

Phrase: "610 622,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

